<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6136800</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0203916</article-id><article-id pub-id-type="publisher-id">PONE-D-17-15987</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV-1</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>North America</subject><subj-group><subject>Central America</subject><subj-group><subject>Guatemala</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>HIV epidemiology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Evolutionary Biology</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject><subj-group><subject>Phylogenetic Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Taxonomy</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject><subj-group><subject>Phylogenetic Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Computer and Information Sciences</subject><subj-group><subject>Data Management</subject><subj-group><subject>Taxonomy</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject><subj-group><subject>Phylogenetic Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Database and Informatics Methods</subject><subj-group><subject>Bioinformatics</subject><subj-group><subject>Sequence Analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Immunodeficiency Viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Database and Informatics Methods</subject><subj-group><subject>Bioinformatics</subject><subj-group><subject>Sequence Analysis</subject><subj-group><subject>Sequence Alignment</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>North America</subject><subj-group><subject>Mexico</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Evolutionary history and spatiotemporal dynamics of the HIV-1 subtype B epidemic in Guatemala</article-title><alt-title alt-title-type="running-head">HIV-1 subtype B molecular epidemiology in Guatemala</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Mendoza</surname><given-names>Yaxelis</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Garc&#x000ed;a-Morales</surname><given-names>Claudia</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Validation</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Bello</surname><given-names>Gonzalo</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Garrido-Rodr&#x000ed;guez</surname><given-names>Daniela</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tapia-Trejo</surname><given-names>Daniela</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pascale</surname><given-names>Juan Miguel</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Supervision</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gir&#x000f3;n-Callejas</surname><given-names>Amalia Carolina</given-names></name><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mendiz&#x000e1;bal-Burastero</surname><given-names>Ricardo</given-names></name><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Escobar-Urias</surname><given-names>Ingrid Yessenia</given-names></name><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Supervision</role><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Garc&#x000ed;a-Gonz&#x000e1;lez</surname><given-names>Blanca Leticia</given-names></name><role content-type="http://credit.casrai.org/">Resources</role><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Navas-Castillo</surname><given-names>Jessenia Sabrina</given-names></name><role content-type="http://credit.casrai.org/">Resources</role><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Quintana-Galindo</surname><given-names>Mar&#x000ed;a Cristina</given-names></name><role content-type="http://credit.casrai.org/">Resources</role><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pinz&#x000f3;n-Meza</surname><given-names>Rodolfo</given-names></name><role content-type="http://credit.casrai.org/">Resources</role><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author" deceased="yes"><name><surname>Mej&#x000ed;a-Villatoro</surname><given-names>Carlos Rodolfo</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><xref ref-type="aff" rid="aff006"><sup>6</sup></xref><xref ref-type="author-notes" rid="econtrib001"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3371-4248</contrib-id><name><surname>Avila-R&#x000ed;os</surname><given-names>Santiago</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="author-notes" rid="econtrib001"><sup>&#x02021;</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Reyes-Ter&#x000e1;n</surname><given-names>Gustavo</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="author-notes" rid="econtrib001"><sup>&#x02021;</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Gorgas Memorial Institute for Health Studies, Panama City, Panama</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Genetics and Molecular Biology, University of Panama, Panama City, Panama</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Centre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Laborat&#x000f3;rio de AIDS e Imunologia Molecular, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Universidad del Valle de Guatemala, Guatemala City, Guatemala</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>Infectious Diseases Clinic, Roosevelt Hospital, Guatemala City, Guatemala</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Sandstrom</surname><given-names>Paul</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Public Health Agency of Canada, CANADA</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="other" id="econtrib001"><p>&#x02021; Joint senior authors.</p></fn><corresp id="cor001">* E-mail: <email>gustavo.reyesteran@gmail.com</email> (GRT); <email>santiago.avila@cieni.org.mx</email> (SAR)</corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>9</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>13</volume><issue>9</issue><elocation-id>e0203916</elocation-id><history><date date-type="received"><day>25</day><month>4</month><year>2017</year></date><date date-type="accepted"><day>30</day><month>8</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 Mendoza et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Mendoza et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0203916.pdf"/><abstract><p>Different explanations exist on how HIV-1 subtype B spread in Central America, but the role of Guatemala, the Central American country with the highest number of people living with the virus, in this scenario is unknown. We investigated the evolutionary history and spatiotemporal dynamics of HIV-1 subtype B in Guatemala. A total of 1,047 HIV-1 subtype B <italic>pol</italic> sequences, from newly diagnosed ART-na&#x000ef;ve, HIV-infected Guatemalan subjects enrolled between 2011 and 2013 were combined with published subtype B sequences from other Central American countries (n = 2,101) and with reference sequences representative of the B<sub>PANDEMIC</sub> and B<sub>CAR</sub> lineages from the United States (n = 465), France (n = 344) and the Caribbean (n = 238). Estimates of evolutionary, demographic, and phylogeographic parameters were obtained from sequence data using maximum likelihood and Bayesian coalescent-based methods. The majority of Guatemalan sequences (98.9%) belonged to the B<sub>PANDEMIC</sub> clade, and 75.2% of these sequences branched within 10 monophyletic clades: four also included sequences from other Central American countries (B<sub>CAM-I</sub> to B<sub>CAM-IV</sub>) and six were mostly (&#x0003e;99%) composed by Guatemalan sequences (B<sub>GU</sub> clades). Most clades mainly comprised sequences from heterosexual individuals. Bayesian coalescent-based analyses suggested that B<sub>GU</sub> clades originated during the 1990s and 2000s, whereas B<sub>CAM</sub> clades originated between the late 1970s and mid 1980s. The major hub of dissemination of all B<sub>GU</sub>, and of B<sub>CAM-II,</sub> and B<sub>CAM-IV</sub> clades was traced to the Department of Guatemala, while the root location of B<sub>CAM-I</sub> and B<sub>CAM-III</sub> was traced to Honduras. Most Guatemalan clades experienced initial phases of exponential growth (0.23 and 3.6 year<sup>-1</sup>), followed by recent growth declines. Our observations suggest that the Guatemalan HIV-1 subtype B epidemic is driven by dissemination of multiple B<sub>PANDEMIC</sub> founder viral strains, some restricted to Guatemala and others widely disseminated in the Central American region, with Guatemala City identified as a major hub of viral dissemination. Our results also suggest the existence of different sub-epidemics within Guatemala for which different targeted prevention efforts might be needed.</p></abstract><funding-group><award-group id="award001"><funding-source><institution>Mexican Government</institution></funding-source><award-id>Comisi&#x000f3;n de Equidad y G&#x000e9;nero de las Legislaturas LX-LXI and Comisi&#x000f3;n de Igualdad de G&#x000e9;nero de la Legislatura LXII de la H. C&#x000e1;mara de Diputados de la Rep&#x000fa;blica Mexicana</award-id><principal-award-recipient><name><surname>Reyes-Ter&#x000e1;n</surname><given-names>Gustavo</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003141</institution-id><institution>Consejo Nacional de Ciencia y Tecnolog&#x000ed;a</institution></institution-wrap></funding-source><award-id>CONACyT SALUD-2013-01-202475</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3371-4248</contrib-id><name><surname>Avila-R&#x000ed;os</surname><given-names>Santiago</given-names></name></principal-award-recipient></award-group><funding-statement>This work was supported by grants from the Mexican Government (Comisi&#x000f3;n de Equidad y G&#x000e9;nero de las Legislaturas LX-LXI y Comisi&#x000f3;n de Igualdad de G&#x000e9;nero de la Legislatura LXII de la H. C&#x000e1;mara de Diputados de la Rep&#x000fa;blica Mexicana), received by GRT, and Consejo Nacional de Ciencia y Tecnolog&#x000ed;a (CONACyT SALUD-2013-01-202475; <ext-link ext-link-type="uri" xlink:href="http://www.conacyt.mx">http://www.conacyt.mx</ext-link>), received by SAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="6"/><table-count count="3"/><page-count count="21"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>It is commonly accepted that the HIV-1 subtype B epidemic likely moved out of Africa via a single introduction to Haiti in the mid 1960s [<xref rid="pone.0203916.ref001" ref-type="bibr">1</xref>]. This event was followed by a wide spread of phylogenetically distinct Caribbean-specific lineages (B<sub>CAR</sub>) throughout the Caribbean islands [<xref rid="pone.0203916.ref001" ref-type="bibr">1</xref>&#x02013;<xref rid="pone.0203916.ref003" ref-type="bibr">3</xref>], with non-pandemic B<sub>CAR</sub> lineages accounting for more than 40% of infections in the region [<xref rid="pone.0203916.ref003" ref-type="bibr">3</xref>]. A pandemic B lineage (B<sub>PANDEMIC</sub>), encompassing most subtype B infections around the world, subsequently emerged in the late 1960s [<xref rid="pone.0203916.ref001" ref-type="bibr">1</xref>], spreading from the Caribbean to North America and later expanding to other parts of the world [<xref rid="pone.0203916.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0203916.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0203916.ref005" ref-type="bibr">5</xref>], including possible re-introductions to the Caribbean [<xref rid="pone.0203916.ref006" ref-type="bibr">6</xref>].</p><p>The precise routes of introduction of HIV-1 subtype B to Central America remain to be clarified. One study suggests that a single early introduction of a B<sub>PANDEMIC</sub> strain possibly to Honduras during the 1960s originated a Central American lineage (B<sub>CAM</sub>) that accounts for approximately 60% of current subtype B cases in the region [<xref rid="pone.0203916.ref007" ref-type="bibr">7</xref>]. Other sub-epidemics originating mostly during the 1970s and early 1980s were generated by the spread of additional founder viruses that tended to cluster according to the country of origin [<xref rid="pone.0203916.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0203916.ref007" ref-type="bibr">7</xref>]. A more detailed study in Panama, however, showed that the subtype B epidemic in this country is mostly driven by the expansion of multiple founder B<sub>PANDEMIC</sub> and B<sub>CAR</sub> strains, that have remained mostly restricted to this country [<xref rid="pone.0203916.ref008" ref-type="bibr">8</xref>].</p><p>Guatemala is the country comprising the highest number of individuals estimated to be living with HIV (49,000) in Central America, with prevalence in the general population of 0.5% [<xref rid="pone.0203916.ref009" ref-type="bibr">9</xref>]. The Guatemalan HIV epidemic is concentrated in most-at-risk groups, with 8.9% prevalence in men who have sex with men (MSM), 23.8% in transgender women and 1.0&#x02013;2.6% in female sex workers (FSW) [<xref rid="pone.0203916.ref010" ref-type="bibr">10</xref>]. It is estimated that men who have sex with men comprise approximately 30% of the total estimated number of persons living with HIV in Guatemala and that heterosexual transmission accounts for 68% of cases [<xref rid="pone.0203916.ref011" ref-type="bibr">11</xref>]. The first AIDS case in Guatemala was recorded in 1984 in a young homosexual man who had resided in the United States, and cases in women were not reported until 1986 [<xref rid="pone.0203916.ref012" ref-type="bibr">12</xref>]. Geographic distribution of the Guatemalan HIV epidemic reflects economic development with the involvement of departments with higher commercial activity and with marked migratory routes, including Guatemala, Escuintla, San Marcos, Retalhuleu, Quetzaltenango, Izabal, Pet&#x000e9;n and Suchitep&#x000e9;quez, which concentrate 76% of notified cases [<xref rid="pone.0203916.ref012" ref-type="bibr">12</xref>]. A higher proportion of cases is found in Ladino (Mestizo) populations (77%) compared to Maya (indigenous) populations (20%), and 60% of infected individuals are male (approximately 60% of the general population is considered Ladino and 40% indigenous) [<xref rid="pone.0203916.ref010" ref-type="bibr">10</xref>]. Nevertheless, the molecular epidemiological history of HIV has not been assessed in Guatemala. For rapidly evolving pathogens such as HIV, phylogenetic methods can contribute to understand the complex dynamics of viral spread at the population level. Moreover, molecular epidemiology studies have the potential to better inform targeted public health interventions to contain the HIV epidemic at the local, national, or regional context, by identifying key clinical, demographic and geographical correlates of transmission. This information can help to focus limited resources to more effective HIV prevention efforts, including for example, the active search for new infection cases to link them to care and the roll out of pre-exposure prophylaxis [<xref rid="pone.0203916.ref013" ref-type="bibr">13</xref>].</p><p>The aim of the present study was to describe the spatiotemporal dynamics of dissemination of HIV subtype B in Guatemala, assessing its possible evolutionary relations with other viruses circulating in the Americas. The study was performed on a large HIV <italic>pol</italic> sequence dataset from individuals enrolled from 2010 to 2013 at the Roosevelt Hospital, one of the national HIV reference centers.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><sec id="sec003"><title>Ethics statement</title><p>This study was evaluated and approved by the Ethics Committees of the National Institute of Respiratory Diseases (INER) in Mexico City (E06-09), and the Roosevelt Hospital in Guatemala City, and was conducted according to the principles of the Declaration of Helsinki. All participants gave written informed consent before blood sample donation.</p></sec><sec id="sec004"><title>Guatemalan HIV-1 <italic>pol</italic> sequences</title><p>Blood samples from 1,083 HIV-1-infected Guatemalan individuals were collected at the Infectious Diseases Clinic of the Roosevelt Hospital in Guatemala City from October 2010 to December 2013 as part of an HIV pre-treatment drug resistance study [<xref rid="pone.0203916.ref014" ref-type="bibr">14</xref>]. Briefly, antiretroviral treatment-na&#x000ef;ve individuals were enrolled in a cross-sectional study according to new clinical diagnoses at spontaneous demand to the clinic, also including individuals on follow-up visits, previous to starting antiretroviral treatment. Every eligible person attending the clinic was invited to participate in the study. No exclusion criteria were applied except for previous exposure to antiretroviral drugs. After giving written informed consent, participants donated a single blood sample. The complete protease (PR) and the first part of the reverse transcriptase (RT) of the pol gene (nucleotides 2253 to 3275 of reference strain HXB2) were amplified and sequenced using an in-house developed methodology as previously described [<xref rid="pone.0203916.ref014" ref-type="bibr">14</xref>]. Sequences used in the study are available at <xref ref-type="supplementary-material" rid="pone.0203916.s001">S1 Data</xref>. Serving 30% of all HIV-infected persons in Guatemala, the Roosevelt Hospital is the largest of a total of 18 clinics providing antiretroviral treatment in the country [<xref rid="pone.0203916.ref015" ref-type="bibr">15</xref>]. Although, the Roosevelt Hospital is located in the Department of Guatemala, the persons that initiate ART in this institution come from all over the country [<xref rid="pone.0203916.ref016" ref-type="bibr">16</xref>], with 45% of clients from other departments [<xref rid="pone.0203916.ref014" ref-type="bibr">14</xref>]. The place of residence distribution of Roosevelt Hospital&#x02019;s clients reflects the national distribution of HIV cases [<xref rid="pone.0203916.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0203916.ref016" ref-type="bibr">16</xref>]. Also, sociodemographic characteristics (including female-to-male ratio, mean age, race, marital status and literacy) of Roosevelt Hospital&#x02019;s clients is similar to those of the national HIV-infected population [<xref rid="pone.0203916.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0203916.ref017" ref-type="bibr">17</xref>].</p></sec><sec id="sec005"><title>HIV-1 subtype B <italic>pol</italic> reference sequences</title><p>The HIV-1 subtype B <italic>pol</italic> sequences from Guatemala were aligned with: 1) subtype B <italic>pol</italic> sequences representative of the B<sub>PANDEMIC</sub>/B<sub>CAR</sub> clades (US/France = 809/Caribbean = 238) [<xref rid="pone.0203916.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0203916.ref008" ref-type="bibr">8</xref>]; 2) Panamanian subtype B <italic>pol</italic> sequences representative of the country-specific clades (<italic>n</italic> = 583) [<xref rid="pone.0203916.ref008" ref-type="bibr">8</xref>]; and 3) all available subtype B <italic>pol</italic> sequences from other Central American countries (<italic>n</italic> = 694) and Mexico (<italic>n</italic> = 824) that matched the above selected genomic region (<xref ref-type="supplementary-material" rid="pone.0203916.s002">S1 Table</xref>). All HIV-1 subtype B <italic>pol</italic> reference sequences used in this study were available at Los Alamos HIV Sequence Database (<ext-link ext-link-type="uri" xlink:href="http://www.hiv.lanl.gov/">www.hiv.lanl.gov</ext-link>) by December 2014.</p></sec><sec id="sec006"><title>Sequence alignment and subtype assignment</title><p>Sequences were aligned using the ClustalW program implemented in Mega 6.0 software [<xref rid="pone.0203916.ref018" ref-type="bibr">18</xref>, <xref rid="pone.0203916.ref019" ref-type="bibr">19</xref>]. The subtype assignment of all sequences included was confirmed using REGA HIV subtyping tool v.2 [<xref rid="pone.0203916.ref020" ref-type="bibr">20</xref>] and by performing Neighbor-Joining (NJ) phylogenetic analyses with HIV-1 group M reference sequences downloaded from Los Alamos HIV Sequence Database. The NJ phylogenies were constructed under the Tamura-Nei evolutionary model and the reliability of tree topologies was assessed by bootstrap analysis with 500 replicates using the MEGA 6.0 software package [<xref rid="pone.0203916.ref019" ref-type="bibr">19</xref>]. Bootstrap values above 75% were considered significant. All sites associated with major antiretroviral drug resistance mutations in PR (30, 32, 46, 47, 48, 50, 54, 76, 82, 84, 88 and 90) or RT (41, 65, 67, 69, 70, 74, 100, 101, 103, 106, 115, 138, 151, 181, 184, 188, 190, 210, 215, 219 and 230) detected in at least two sequences, were excluded from each dataset. All alignments are available from the authors upon request.</p></sec><sec id="sec007"><title>Phylogenetic analysis</title><p>Maximum Likelihood (ML) phylogenetic trees were inferred under GTR+I+&#x00393;<sub>4</sub> nucleotide substitution model selected using the jModeltest program [<xref rid="pone.0203916.ref021" ref-type="bibr">21</xref>]. The ML tree was reconstructed with the PhyML program [<xref rid="pone.0203916.ref022" ref-type="bibr">22</xref>] using an online web server [<xref rid="pone.0203916.ref023" ref-type="bibr">23</xref>]. Heuristic tree search was performed using the SPR branch-swapping algorithm and the reliability of the obtained topology was estimated with the approximate likelihood-ratio test (<italic>aLRT</italic>) [<xref rid="pone.0203916.ref024" ref-type="bibr">24</xref>] based on the Shimodaira-Hasegawa-like procedure. <italic>aLRT</italic> values above 0.8 were considered significant. The ML trees were visualized using the FigTree v1.4.0 program [<xref rid="pone.0203916.ref025" ref-type="bibr">25</xref>].</p></sec><sec id="sec008"><title>Analysis of spatiotemporal dispersion patterns</title><p>The evolutionary rate (nucleotide substitutions per site per year, subst./site/year), the age of the most recent common ancestor (<italic>T</italic><sub>mrca,</sub> years) and the spatial diffusion of HIV-1 Guatemalan clades were jointly estimated using the Bayesian Markov Chain Monte Carlo (MCMC) approach as implemented in BEAST v1.8 [<xref rid="pone.0203916.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0203916.ref027" ref-type="bibr">27</xref>] with BEAGLE [<xref rid="pone.0203916.ref028" ref-type="bibr">28</xref>]. Analyses were performed using the GTR+I+&#x00393;<sub>4</sub> nucleotide substitution model and the temporal scale of evolutionary process was directly estimated from the sampling dates of the sequences using a relaxed uncorrelated lognormal molecular clock model [<xref rid="pone.0203916.ref029" ref-type="bibr">29</xref>]. Migration events throughout the phylogenetic histories were reconstructed using a reversible discrete phylogeography model [<xref rid="pone.0203916.ref030" ref-type="bibr">30</xref>]. Adequate chain mixing and uncertainty in parameter estimates were assessed by calculating the effective sample size (ESS) and the 95% Highest Posterior Density (HPD) values respectively using the TRACER v1.5 program [<xref rid="pone.0203916.ref031" ref-type="bibr">31</xref>]. Maximum clade credibility (MCC) trees were summarized with TreeAnnotator v1.8.1 and visualized with FigTree v1.4.0. Migratory events were summarized using the SPREAD application [<xref rid="pone.0203916.ref032" ref-type="bibr">32</xref>].</p></sec><sec id="sec009"><title>Reconstruction of demographic history</title><p>The mode and rate (<italic>r</italic>, years<sup>-1</sup>) of population growth of major HIV-1 clades circulating in Guatemala was also estimated using BEAST v1.8 software. Analyses were also performed using the GTR+I+&#x00393;<sub>4</sub> nucleotide substitution model and the temporal scale of evolutionary process were estimated using a relaxed uncorrelated lognormal molecular clock model. Changes in effective population size through time were initially estimated using a Bayesian Skyline coalescent tree prior [<xref rid="pone.0203916.ref033" ref-type="bibr">33</xref>] and estimates of the population growth rate were subsequently obtained using the parametric model (logistic, exponential or expansion) that provided the best fit to the demographic signal contained in datasets. Comparison between demographic models was performed using the log marginal likelihood (ML) estimation based on path sampling (PS) and stepping-stone sampling (SS) methods [<xref rid="pone.0203916.ref034" ref-type="bibr">34</xref>]. MCMC chains were run for 50&#x02013;500 &#x000d7; 10<sup>6</sup> generations. Convergence and uncertainty of parameter estimates were assessed as explained above.</p></sec><sec id="sec010"><title>Statistical analysis</title><p>Demographic and clinical variables of individuals belonging to the different clades were compared using linear regression or Chi-square test according to variable type. False Discovery Rate (FDR) for multiple comparisons was estimated with Storey q-values. The threshold for significance was set at p&#x0003c;0.05 and q&#x0003c;0.2. Analysis was performed using STATA/SE version 14 (StataCorp, College Station, TX).</p></sec></sec><sec sec-type="results" id="sec011"><title>Results</title><sec id="sec012"><title>Most HIV-1 subtype B Guatemalan sequences belong to the B<sub>PANDEMIC</sub> clade</title><p>Of the 1,083 HIV-1 <italic>pol</italic> Guatemalan sequences here analyzed, we selected 1,047 subtype B sequences geographically distributed among the 22 departments of Guatemala. The remaining 36 sequences were excluded because of possible quality issues (unusual indel mutations/rare polymorphisms) (<italic>n</italic> = 21) or non-B subtype classification (<italic>n</italic> = 15). In order to better understand the origin of the Guatemalan HIV-1 subtype B epidemic, Guatemalan sequences were combined with representative sequences of the B<sub>PANDEMIC</sub> and B<sub>CAR</sub> lineages (<xref ref-type="supplementary-material" rid="pone.0203916.s002">S1 Table</xref>) to perform a phylogenetic analysis. The ML analysis revealed that, as expected, the B<sub>CAR</sub> sequences occupied the deepest branches within the subtype B phylogeny; whereas the B<sub>PANDEMIC</sub> sequences branched as a well-supported (<italic>aLRT</italic> = 0.88) monophyletic subgroup nested within the B<sub>CAR</sub> clades (<xref ref-type="fig" rid="pone.0203916.g001">Fig 1</xref>). Of the 1,047 sequences analyzed from Guatemala, 1,036 (98.9%) branched within the B<sub>PANDEMIC</sub> clade and only 11 sequences (1.1%) branched among the B<sub>CAR</sub> lineages (<xref ref-type="fig" rid="pone.0203916.g001">Fig 1</xref>). This analysis also revealed that 787 (75.2%) of the Guatemalan sequences branched in 10 country-specific monophyletic clades of large size (29 &#x02264; <italic>n</italic> &#x02264; 209; B<sub>GU-I</sub> to B<sub>GU-X</sub>), 226 (21.6%) branched in 43 country-specific clusters of small size (2 &#x02264; <italic>n</italic> &#x02264; 17), and the remaining 34 (3.2%) represented non-clustered sequences (<xref ref-type="fig" rid="pone.0203916.g001">Fig 1</xref>).</p><fig id="pone.0203916.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0203916.g001</object-id><label>Fig 1</label><caption><title>Maximum likelihood phylogenetic tree of HIV-1 subtype B <italic>pol</italic> (~1000 pb) sequences circulating in Guatemala (<italic>n</italic> = 1047), and representative sequences of the B<sub>PANDEMIC</sub> (US = 465, France = 344) and the B<sub>CAR</sub> (Caribbean = 238) clades.</title><p>Branches are colored according to the geographic origin of each sequence, as indicated in the legend (top left). Colored boxes highlight the position of the ten major Guatemalan HIV-1 subtype B clades (B<sub>GU-I</sub> to B<sub>GU-X</sub>). The number of sequences and the <italic>a</italic>LRT support values for each clade are indicated at the bottom. The tree was rooted using HIV-1 subtype D reference sequences. Branch lengths are drawn to scale with the bar at the bottom indicating nucleotide substitutions per site.</p></caption><graphic xlink:href="pone.0203916.g001"/></fig></sec><sec id="sec013"><title>Identification of country- and region-specific HIV-1 subtype B clades</title><p>HIV-1 subtype B sequences from the largest Guatemalan clades here identified were next aligned with subtype B sequences from Mexico, Panama and other Central American countries (<xref ref-type="supplementary-material" rid="pone.0203916.s002">S1 Table</xref>). ML analysis revealed that all sequences from Panama and Costa Rica and most sequences from Mexico (98%) branched outside the major Guatemalan clades (Figs <xref ref-type="fig" rid="pone.0203916.g002">2</xref> and <xref ref-type="fig" rid="pone.0203916.g003">3</xref>). By contrast, a large proportion of sequences from Honduras (92%), El Salvador (54%), and Belize (22%) branched within the previously defined Guatemalan clades B<sub>GU-IV</sub>, B<sub>GU-VII</sub>, B<sub>GU-IX</sub> and B<sub>GU-X</sub> that were thus reclassified as Central American clades B<sub>CAM-IV</sub>, B<sub>CAM-II</sub>, B<sub>CAM-III</sub> and B<sub>CAM-I</sub>, respectively (<xref ref-type="fig" rid="pone.0203916.g002">Fig 2</xref>). The prevalence of each major Central American clade greatly varied among countries (<xref ref-type="supplementary-material" rid="pone.0203916.s003">S2 Table</xref>). In Guatemala, the predominant clade was B<sub>CAM-I</sub> (19%), followed by clades B<sub>CAM-II</sub> (12%), B<sub>CAM-IV</sub> (10%) and B<sub>CAM-III</sub> (8%). In Honduras, the most prevalent clade was B<sub>CAM-I</sub> (73%), followed by clades B<sub>CAM-III</sub> (12%) and B<sub>CAM-II</sub> (7%). In El Salvador, the predominant clade was B<sub>CAM-II</sub> (34%), followed by clades B<sub>CAM-IV</sub> (12%) and B<sub>CAM-I</sub> (8%). In Belize, B<sub>CAM-I</sub> and B<sub>CAM-II</sub> clades seemed to circulate with similar prevalence (11%). Guatemalan clades (B<sub>GU-I</sub>, B<sub>GU-II</sub>, B<sub>GU-III,</sub> B<sub>GU-V</sub>, B<sub>GU-VI</sub> and B<sub>GU-VIII</sub>) were mostly (&#x0003e;99%) composed by sequences from that country and were thus classified as country-specific clades. Among subtype B sequences from Guatemala included in the study (<italic>n</italic> = 1,047), 49.3% (<italic>n</italic> = 516) belonged to Central America-specific clades and 23.8% (<italic>n</italic> = 249) belonged to Guatemala-specific clades.</p><fig id="pone.0203916.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0203916.g002</object-id><label>Fig 2</label><caption><title>Maximum likelihood phylogenetic tree of HIV-1 subtype B <italic>pol</italic> (~1000 pb) sequences belonging to the major Guatemalan clades (B<sub>GU-I</sub> to B<sub>GU-X,</sub> n = 787), and reference sequences from various Central American countries (<italic>n</italic> = 694), Panama (<italic>n</italic> = 583), and the Caribbean (<italic>n</italic> = 238).</title><p>Branches are colored according to the geographic origin of each sequence, as indicated in the legend (top left). Colored boxes highlight the position of the six major Guatemalan HIV-1 subtype B clades (B<sub>GUs</sub>) and the four Central American clades (B<sub>CAM-I</sub> to B<sub>CAM-VI</sub>). The number of sequences and <italic>a</italic>LRT support values for each clade are indicated at the bottom. The tree was rooted using HIV-1 subtype D reference sequences. Branch lengths are drawn to scale with the bar at the bottom indicating nucleotide substitutions per site.</p></caption><graphic xlink:href="pone.0203916.g002"/></fig><fig id="pone.0203916.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0203916.g003</object-id><label>Fig 3</label><caption><title>Maximum likelihood phylogenetic tree of HIV-1 subtype B <italic>pol</italic> (~1000 bp) sequences belonging to the major Guatemalan clades (B<sub>GU-I</sub> to B<sub>GU-X,</sub> n = 787), and reference sequences from Mexico (<italic>n</italic> = 824) and the Caribbean (<italic>n</italic> = 238).</title><p>Branches are colored according to the geographic origin of each sequence, as indicated in the legend (top left). Branches from clades B<sub>GU-I</sub> to B<sub>GU-X</sub> are colored according to clade as indicated in the legend (bottom). The tree was rooted using HIV-1 subtype D reference sequences. Branch lengths are drawn to scale with the bar at the bottom indicating nucleotide substitutions per site.</p></caption><graphic xlink:href="pone.0203916.g003"/></fig></sec><sec id="sec014"><title>Epidemiological characteristics of Guatemalan subjects across major HIV-1 subtype B clades circulating in Central America</title><p>We then analyzed the demographic and clinical characteristics of individuals included in the different Guatemalan and Central American clades (<xref rid="pone.0203916.t001" ref-type="table">Table 1</xref>). Significant differences in all the variables analyzed were observed between the B<sub>GU-II</sub> clade and the other B<sub>CAM</sub> and B<sub>GU</sub> lineages. The B<sub>GU-II</sub> clade was mostly transmitted among young (median age 27 years), recently infected (59%), MSM (46%), with higher education level (71% with bachelor degree and 16% with high-school degree) and employment (64%) rates. In sharp contrast, all other B<sub>CAM</sub> and B<sub>GU</sub> clades were mostly composed of older (median age &#x0003e;31 years), heterosexual (&#x0003e;79%) individuals, with long-standing infection (&#x0003e;78%), and lower education (degree &#x0003c;21%) and employment (&#x0003c;53%) rates than those observed in individuals infected by the B<sub>GU-II</sub> clade. Guatemala City was the residence for most (&#x0003e;48%) individuals of major B<sub>CAM</sub> and B<sub>GU</sub> clades, with exception of B<sub>GU-V</sub> (24%) and B<sub>CAM-III</sub> (34%). The B<sub>GU-V</sub> clade stands out due to a lower mean CD4 T cell count. This clade was composed by persons from outside the Department of Guatemala (77%), with a significantly lower level of education (35% with none and 53% with elementary degree) and heterosexual risk of transmission. Late arrival to clinical care in populations with lower education and socio-economic status is a common feature of many Latin American countries [<xref rid="pone.0203916.ref035" ref-type="bibr">35</xref>]. This may explain the common feature of low CD4 T cell counts at the time of HIV diagnosis.</p><table-wrap id="pone.0203916.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0203916.t001</object-id><label>Table 1</label><caption><title>Clinical and demographic characteristics of individuals included in the large Guatemalan and Central American clusters.</title></caption><alternatives><graphic id="pone.0203916.t001g" xlink:href="pone.0203916.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">All clusters</th><th align="center" rowspan="1" colspan="1">B GU-I</th><th align="center" rowspan="1" colspan="1">B GU-II</th><th align="center" rowspan="1" colspan="1">B GU-III</th><th align="center" rowspan="1" colspan="1">B GU-V</th><th align="center" rowspan="1" colspan="1">B GU-VI</th><th align="center" rowspan="1" colspan="1">B GU-VIII</th><th align="center" rowspan="1" colspan="1">B CAM I</th><th align="center" rowspan="1" colspan="1">B CAM II</th><th align="center" rowspan="1" colspan="1">B CAM III</th><th align="center" rowspan="1" colspan="1">B CAM IV</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>n</bold></td><td align="center" rowspan="1" colspan="1">765</td><td align="center" rowspan="1" colspan="1">67</td><td align="center" rowspan="1" colspan="1">44</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">197</td><td align="center" rowspan="1" colspan="1">129</td><td align="center" rowspan="1" colspan="1">86</td><td align="center" rowspan="1" colspan="1">104</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>%</bold></td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">8.8</td><td align="center" rowspan="1" colspan="1">5.8</td><td align="center" rowspan="1" colspan="1">3.8</td><td align="center" rowspan="1" colspan="1">4.4</td><td align="center" rowspan="1" colspan="1">5.2</td><td align="center" rowspan="1" colspan="1">4.6</td><td align="center" rowspan="1" colspan="1">25.8</td><td align="center" rowspan="1" colspan="1">16.9</td><td align="center" rowspan="1" colspan="1">11.2</td><td align="center" rowspan="1" colspan="1">13.6</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Age (years)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Median</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1"><bold>27</bold></td><td align="center" rowspan="1" colspan="1"><bold>40</bold></td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">34</td></tr><tr><td align="left" rowspan="1" colspan="1">IQR</td><td align="center" rowspan="1" colspan="1">28&#x02013;44</td><td align="center" rowspan="1" colspan="1">29&#x02013;46</td><td align="center" rowspan="1" colspan="1"><bold>22&#x02013;30</bold></td><td align="center" rowspan="1" colspan="1"><bold>31&#x02013;51</bold></td><td align="center" rowspan="1" colspan="1">28&#x02013;42</td><td align="center" rowspan="1" colspan="1">29&#x02013;43</td><td align="center" rowspan="1" colspan="1">29&#x02013;48</td><td align="center" rowspan="1" colspan="1">30&#x02013;44</td><td align="center" rowspan="1" colspan="1">29&#x02013;45</td><td align="center" rowspan="1" colspan="1">27&#x02013;44</td><td align="center" rowspan="1" colspan="1">29&#x02013;43</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Gender (%)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">43.9</td><td align="center" rowspan="1" colspan="1">52.2</td><td align="center" rowspan="1" colspan="1"><bold>6.8</bold></td><td align="center" rowspan="1" colspan="1">44.8</td><td align="center" rowspan="1" colspan="1">44.1</td><td align="center" rowspan="1" colspan="1">52.5</td><td align="center" rowspan="1" colspan="1"><bold>65.7</bold></td><td align="center" rowspan="1" colspan="1">45.2</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">46.5</td><td align="center" rowspan="1" colspan="1">37.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">56.1</td><td align="center" rowspan="1" colspan="1">47.8</td><td align="center" rowspan="1" colspan="1"><bold>93.2</bold></td><td align="center" rowspan="1" colspan="1">55.2</td><td align="center" rowspan="1" colspan="1">55.9</td><td align="center" rowspan="1" colspan="1">47.5</td><td align="center" rowspan="1" colspan="1"><bold>34.3</bold></td><td align="center" rowspan="1" colspan="1">54.8</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1">53.5</td><td align="center" rowspan="1" colspan="1">62.5</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Civil Status (%)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Single</td><td align="center" rowspan="1" colspan="1">38.8</td><td align="center" rowspan="1" colspan="1">29.9</td><td align="center" rowspan="1" colspan="1"><bold>81.8</bold></td><td align="center" rowspan="1" colspan="1">55.2</td><td align="center" rowspan="1" colspan="1">29.4</td><td align="center" rowspan="1" colspan="1">32.5</td><td align="center" rowspan="1" colspan="1">42.9</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1"><bold>31</bold></td><td align="center" rowspan="1" colspan="1"><bold>38.4</bold></td><td align="center" rowspan="1" colspan="1">43.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Married</td><td align="center" rowspan="1" colspan="1">24.2</td><td align="center" rowspan="1" colspan="1"><bold>34.3</bold></td><td align="center" rowspan="1" colspan="1"><bold>9.1</bold></td><td align="center" rowspan="1" colspan="1">24.1</td><td align="center" rowspan="1" colspan="1"><bold>38.2</bold></td><td align="center" rowspan="1" colspan="1">22.5</td><td align="center" rowspan="1" colspan="1">22.9</td><td align="center" rowspan="1" colspan="1"><bold>18.3</bold></td><td align="center" rowspan="1" colspan="1">29.5</td><td align="center" rowspan="1" colspan="1">23.3</td><td align="center" rowspan="1" colspan="1">26</td></tr><tr><td align="left" rowspan="1" colspan="1">Domestic Partnership</td><td align="center" rowspan="1" colspan="1">27.6</td><td align="center" rowspan="1" colspan="1">26.9</td><td align="center" rowspan="1" colspan="1"><bold>6.8</bold></td><td align="center" rowspan="1" colspan="1">13.8</td><td align="center" rowspan="1" colspan="1">26.5</td><td align="center" rowspan="1" colspan="1"><bold>35</bold></td><td align="center" rowspan="1" colspan="1">28.6</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">31.8</td><td align="center" rowspan="1" colspan="1">25.6</td><td align="center" rowspan="1" colspan="1">20.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Divorced</td><td align="center" rowspan="1" colspan="1">1.31</td><td align="center" rowspan="1" colspan="1">1.49</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1.52</td><td align="center" rowspan="1" colspan="1">0.78</td><td align="center" rowspan="1" colspan="1">1.16</td><td align="center" rowspan="1" colspan="1">2.88</td></tr><tr><td align="left" rowspan="1" colspan="1">Widow</td><td align="center" rowspan="1" colspan="1">8.1</td><td align="center" rowspan="1" colspan="1">7.5</td><td align="center" rowspan="1" colspan="1">2.3</td><td align="center" rowspan="1" colspan="1">6.9</td><td align="center" rowspan="1" colspan="1">5.9</td><td align="center" rowspan="1" colspan="1">7.5</td><td align="center" rowspan="1" colspan="1">5.7</td><td align="center" rowspan="1" colspan="1">10.2</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">11.6</td><td align="center" rowspan="1" colspan="1">7.7</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Education (%)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">None</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">26.9</td><td align="center" rowspan="1" colspan="1"><bold>4.6</bold></td><td align="center" rowspan="1" colspan="1">24.1</td><td align="center" rowspan="1" colspan="1"><bold>35.3</bold></td><td align="center" rowspan="1" colspan="1">22.5</td><td align="center" rowspan="1" colspan="1">22.9</td><td align="center" rowspan="1" colspan="1">15.2</td><td align="center" rowspan="1" colspan="1">24.8</td><td align="center" rowspan="1" colspan="1">17.4</td><td align="center" rowspan="1" colspan="1"><bold>11.5</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Elementary</td><td align="center" rowspan="1" colspan="1">50.6</td><td align="center" rowspan="1" colspan="1">56.7</td><td align="center" rowspan="1" colspan="1"><bold>9.1</bold></td><td align="center" rowspan="1" colspan="1">51.7</td><td align="center" rowspan="1" colspan="1">52.9</td><td align="center" rowspan="1" colspan="1">52.5</td><td align="center" rowspan="1" colspan="1">54.3</td><td align="center" rowspan="1" colspan="1">54.3</td><td align="center" rowspan="1" colspan="1">52.7</td><td align="center" rowspan="1" colspan="1">53.5</td><td align="center" rowspan="1" colspan="1">49</td></tr><tr><td align="left" rowspan="1" colspan="1">High-school</td><td align="center" rowspan="1" colspan="1">15.6</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">15.9</td><td align="center" rowspan="1" colspan="1">3.4</td><td align="center" rowspan="1" colspan="1">8.8</td><td align="center" rowspan="1" colspan="1">12.5</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">16.2</td><td align="center" rowspan="1" colspan="1">13.2</td><td align="center" rowspan="1" colspan="1"><bold>24.4</bold></td><td align="center" rowspan="1" colspan="1">19.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Degree</td><td align="center" rowspan="1" colspan="1">14.9</td><td align="center" rowspan="1" colspan="1">7.5</td><td align="center" rowspan="1" colspan="1"><bold>70.5</bold></td><td align="center" rowspan="1" colspan="1">20.7</td><td align="center" rowspan="1" colspan="1"><bold>2.9</bold></td><td align="center" rowspan="1" colspan="1">12.5</td><td align="center" rowspan="1" colspan="1"><bold>2.9</bold></td><td align="center" rowspan="1" colspan="1">14.2</td><td align="center" rowspan="1" colspan="1"><bold>9.3</bold></td><td align="center" rowspan="1" colspan="1"><bold>4.7</bold></td><td align="center" rowspan="1" colspan="1">20.2</td></tr><tr><td align="left" colspan="2" rowspan="1"><bold>Employment (%)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Employed</td><td align="center" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1">49.3</td><td align="center" rowspan="1" colspan="1"><bold>63.6</bold></td><td align="center" rowspan="1" colspan="1">51.7</td><td align="center" rowspan="1" colspan="1">52.9</td><td align="center" rowspan="1" colspan="1">37.5</td><td align="center" rowspan="1" colspan="1">34.3</td><td align="center" rowspan="1" colspan="1">42.6</td><td align="center" rowspan="1" colspan="1">50.4</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">43.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Unemployed</td><td align="center" rowspan="1" colspan="1">54</td><td align="center" rowspan="1" colspan="1">50.7</td><td align="center" rowspan="1" colspan="1"><bold>36.4</bold></td><td align="center" rowspan="1" colspan="1">48.3</td><td align="center" rowspan="1" colspan="1">47.1</td><td align="center" rowspan="1" colspan="1">62.5</td><td align="center" rowspan="1" colspan="1">65.7</td><td align="center" rowspan="1" colspan="1">57.4</td><td align="center" rowspan="1" colspan="1">49.6</td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">56.7</td></tr><tr><td align="left" colspan="2" rowspan="1"><bold>Recency of infection (%)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Recent</td><td align="center" rowspan="1" colspan="1">18.3</td><td align="center" rowspan="1" colspan="1">13.4</td><td align="center" rowspan="1" colspan="1"><bold>59.1</bold></td><td align="center" rowspan="1" colspan="1">6.9</td><td align="center" rowspan="1" colspan="1">8.8</td><td align="center" rowspan="1" colspan="1">7.5</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">16.2</td><td align="center" rowspan="1" colspan="1">15.5</td><td align="center" rowspan="1" colspan="1">22.1</td><td align="center" rowspan="1" colspan="1">18.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Long-standing</td><td align="center" rowspan="1" colspan="1">81.7</td><td align="center" rowspan="1" colspan="1">86.6</td><td align="center" rowspan="1" colspan="1"><bold>40.9</bold></td><td align="center" rowspan="1" colspan="1">93.1</td><td align="center" rowspan="1" colspan="1">91.2</td><td align="center" rowspan="1" colspan="1">92.5</td><td align="center" rowspan="1" colspan="1">80</td><td align="center" rowspan="1" colspan="1">83.8</td><td align="center" rowspan="1" colspan="1">84.5</td><td align="center" rowspan="1" colspan="1">77.9</td><td align="center" rowspan="1" colspan="1">81.7</td></tr><tr><td align="left" colspan="2" rowspan="1"><bold>HIV risk factor (%)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Heterosexual</td><td align="center" rowspan="1" colspan="1">87.6</td><td align="center" rowspan="1" colspan="1"><bold>97</bold></td><td align="center" rowspan="1" colspan="1"><bold>38.6</bold></td><td align="center" rowspan="1" colspan="1">86.2</td><td align="center" rowspan="1" colspan="1">94.1</td><td align="center" rowspan="1" colspan="1">90</td><td align="center" rowspan="1" colspan="1">94.3</td><td align="center" rowspan="1" colspan="1"><bold>93.4</bold></td><td align="center" rowspan="1" colspan="1">90.7</td><td align="center" rowspan="1" colspan="1">91.9</td><td align="center" rowspan="1" colspan="1"><bold>78.9</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">MSM</td><td align="center" rowspan="1" colspan="1">8.2</td><td align="center" rowspan="1" colspan="1"><bold>0</bold></td><td align="center" rowspan="1" colspan="1"><bold>45.5</bold></td><td align="center" rowspan="1" colspan="1">6.9</td><td align="center" rowspan="1" colspan="1">2.9</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2.9</td><td align="center" rowspan="1" colspan="1"><bold>3.6</bold></td><td align="center" rowspan="1" colspan="1">7.8</td><td align="center" rowspan="1" colspan="1"><bold>2.3</bold></td><td align="center" rowspan="1" colspan="1"><bold>17.3</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Bisexual</td><td align="center" rowspan="1" colspan="1">3.3</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">15.9</td><td align="center" rowspan="1" colspan="1">6.9</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2.9</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1.6</td><td align="center" rowspan="1" colspan="1">3.5</td><td align="center" rowspan="1" colspan="1">2.9</td></tr><tr><td align="left" rowspan="1" colspan="1">PWID</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1.2</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Other/Unknown</td><td align="center" rowspan="1" colspan="1">0.4</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1"><bold>2.9</bold></td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1.2</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Residence (%)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Guatemala City</td><td align="center" rowspan="1" colspan="1">53.1</td><td align="center" rowspan="1" colspan="1">49.3</td><td align="center" rowspan="1" colspan="1"><bold>77.3</bold></td><td align="center" rowspan="1" colspan="1"><bold>79.3</bold></td><td align="center" rowspan="1" colspan="1"><bold>23.5</bold></td><td align="center" rowspan="1" colspan="1">52.5</td><td align="center" rowspan="1" colspan="1">48.6</td><td align="center" rowspan="1" colspan="1">55.3</td><td align="center" rowspan="1" colspan="1">48.1</td><td align="center" rowspan="1" colspan="1"><bold>33.7</bold></td><td align="center" rowspan="1" colspan="1"><bold>67.3</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Not Guatemala City</td><td align="center" rowspan="1" colspan="1">46.9</td><td align="center" rowspan="1" colspan="1">50.7</td><td align="center" rowspan="1" colspan="1"><bold>22.7</bold></td><td align="center" rowspan="1" colspan="1"><bold>20.7</bold></td><td align="center" rowspan="1" colspan="1"><bold>76.5</bold></td><td align="center" rowspan="1" colspan="1">47.5</td><td align="center" rowspan="1" colspan="1">51.4</td><td align="center" rowspan="1" colspan="1">44.7</td><td align="center" rowspan="1" colspan="1">51.9</td><td align="center" rowspan="1" colspan="1"><bold>66.3</bold></td><td align="center" rowspan="1" colspan="1"><bold>32.7</bold></td></tr><tr><td align="left" colspan="2" rowspan="1"><bold>Viral Load (log copies/mL)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean</td><td align="center" rowspan="1" colspan="1">4.86</td><td align="center" rowspan="1" colspan="1"><bold>5.1</bold></td><td align="center" rowspan="1" colspan="1">4.89</td><td align="center" rowspan="1" colspan="1">4.96</td><td align="center" rowspan="1" colspan="1">4.82</td><td align="center" rowspan="1" colspan="1">4.87</td><td align="center" rowspan="1" colspan="1">4.86</td><td align="center" rowspan="1" colspan="1">4.85</td><td align="center" rowspan="1" colspan="1">4.74</td><td align="center" rowspan="1" colspan="1"><bold>5.09</bold></td><td align="center" rowspan="1" colspan="1"><bold>4.67</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">IQR</td><td align="center" rowspan="1" colspan="1">4.34&#x02013;5.37</td><td align="center" rowspan="1" colspan="1"><bold>4.47&#x02013;5.62</bold></td><td align="center" rowspan="1" colspan="1">4.44&#x02013;5.26</td><td align="center" rowspan="1" colspan="1">4.59&#x02013;5.47</td><td align="center" rowspan="1" colspan="1">4.47&#x02013;5.18</td><td align="center" rowspan="1" colspan="1">4.39&#x02013;5.33</td><td align="center" rowspan="1" colspan="1">4.16&#x02013;5.38</td><td align="center" rowspan="1" colspan="1">4.23&#x02013;5.38</td><td align="center" rowspan="1" colspan="1">4.24&#x02013;5.15</td><td align="center" rowspan="1" colspan="1"><bold>4.44&#x02013;5.53</bold></td><td align="center" rowspan="1" colspan="1"><bold>4.10&#x02013;5.13</bold></td></tr><tr><td align="left" colspan="2" rowspan="1"><bold>CD4+ T cell count (cells/&#x003bc;L)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mean</td><td align="center" rowspan="1" colspan="1">167</td><td align="center" rowspan="1" colspan="1">146</td><td align="center" rowspan="1" colspan="1"><bold>399</bold></td><td align="center" rowspan="1" colspan="1">157</td><td align="center" rowspan="1" colspan="1"><bold>80</bold></td><td align="center" rowspan="1" colspan="1">142</td><td align="center" rowspan="1" colspan="1">214</td><td align="center" rowspan="1" colspan="1">156</td><td align="center" rowspan="1" colspan="1">139</td><td align="center" rowspan="1" colspan="1">172</td><td align="center" rowspan="1" colspan="1">178</td></tr><tr><td align="left" rowspan="1" colspan="1">IQR</td><td align="center" rowspan="1" colspan="1">66&#x02013;346</td><td align="center" rowspan="1" colspan="1">81&#x02013;327</td><td align="center" rowspan="1" colspan="1"><bold>256&#x02013;481</bold></td><td align="center" rowspan="1" colspan="1">62&#x02013;330</td><td align="center" rowspan="1" colspan="1"><bold>29&#x02013;206</bold></td><td align="center" rowspan="1" colspan="1">52&#x02013;297</td><td align="center" rowspan="1" colspan="1">90&#x02013;362</td><td align="center" rowspan="1" colspan="1">61&#x02013;353</td><td align="center" rowspan="1" colspan="1">66&#x02013;309</td><td align="center" rowspan="1" colspan="1">65&#x02013;292</td><td align="center" rowspan="1" colspan="1">82&#x02013;388</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>Significant values (each cluster vs. all the other clusters; p&#x0003c;0.5, q&#x0003c;0.2) are shown in bold.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec015"><title>Spatiotemporal dissemination of major HIV-1 subtype B clades circulating in Central America</title><p>The median estimated evolutionary rates at HIV-1 <italic>pol</italic> gene for major Guatemalan and Central American HIV-1 clades ranged from 2.1 x 10<sup>&#x02212;3</sup> subst./site/year to 2.9 x 10<sup>&#x02212;3</sup> subst./site/year with a great overlap of 95% HPD intervals, whereas the coefficient of variation ranged from 0.33 (0.14&#x02013;0.50) to 0.55 (0.34&#x02013;0.76), thus supporting the use of a relaxed molecular clock model (<xref rid="pone.0203916.t002" ref-type="table">Table 2</xref>). The HIV-1 subtype B Guatemalan clades B<sub>GU-III</sub>, B<sub>GU-V</sub>, B<sub>GU-VI</sub> and B<sub>GU-VIII</sub> arose between the early and the middle 1990s, followed by clades B<sub>GU-I</sub> and B<sub>GU-II</sub> between the early and the middle 2000s (<xref rid="pone.0203916.t002" ref-type="table">Table 2</xref>). The phylogeographic analysis showed that the department of Guatemala was the most probable epicenter of dissemination of all those Guatemalan clades (<italic>PSP</italic>&#x02265;0.86). B<sub>GU-I</sub> was the most widely disseminated lineage, being detected in 15 out of the 22 Guatemalan departments, followed by clade B<sub>GU-V</sub> detected in 11 departments and El Salvador; clade B<sub>GU-VIII</sub> detected in 11 departments, clade B<sub>GU-VI</sub> in 10 departments; clade B<sub>GU-II</sub> in seven departments, and clade B<sub>GU-III</sub> in six departments and Mexico (<xref ref-type="fig" rid="pone.0203916.g004">Fig 4</xref>). The departments of Alta Verapaz, Quiche, Sacatepequez and Santa Rosa were also detected as secondary disseminating locations of clades B<sub>GU-V</sub>, B<sub>GU-I</sub>/B<sub>GU-II</sub>/B<sub>GU-VIII</sub>, B<sub>GU-III</sub> and B<sub>GU-II</sub>, respectively (<xref ref-type="fig" rid="pone.0203916.g004">Fig 4</xref>).</p><fig id="pone.0203916.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0203916.g004</object-id><label>Fig 4</label><caption><title>Spatial dissemination of HIV-1 country-specific Guatemalan clades (B<sub>GU</sub>).</title><p>Lines between departments and neighboring countries represent branches in the Bayesian MCC tree along which location transitions occur. Lines were colored according to the source location as indicated in the legend at the bottom. Dashed lines indicate transitions associated to nodes with low location probability support (&#x0003c;0.60). Guatemalan Departments: Alta Verapaz (AV), Baja Verapaz (BV), Chimaltenango (CM), Chiquimula (CQ), El Progreso (PR), Escuintla (ES), Guatemala (GU), Huehuelenango (HU), IZABAL (IZ), Jalapa (JA), Jutiapa (JU), PETEN (PE), Quetzaltenango (QT), Quiche (QC), Retalhuleu (RE), Sacatepequez (SA), San Marcos (SM), Santa Rosa (SR), Solola (SO), Suchitepequez (SU), Totonicapan (TO) and Zacapa (ZA).</p></caption><graphic xlink:href="pone.0203916.g004"/></fig><table-wrap id="pone.0203916.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0203916.t002</object-id><label>Table 2</label><caption><title>Evolutionary rate and time-scale estimates of B<sub>GU</sub> and B<sub>CAM</sub> clades.</title></caption><alternatives><graphic id="pone.0203916.t002g" xlink:href="pone.0203916.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Clade</th><th align="center" rowspan="1" colspan="1"><italic>N</italic></th><th align="center" rowspan="1" colspan="1">Sampling interval</th><th align="center" rowspan="1" colspan="1"><italic>&#x003bc;</italic> (subst./site/year)<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></th><th align="center" rowspan="1" colspan="1">Variation Coefficient<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></th><th align="center" rowspan="1" colspan="1">T<sub><italic>MRCA</italic></sub><xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">B<sub>GU-I</sub></td><td align="center" rowspan="1" colspan="1">67</td><td align="center" rowspan="1" colspan="1">2010&#x02013;2013</td><td align="center" rowspan="1" colspan="1">2.2&#x000d7;10<sup>&#x02212;3</sup> (1.5&#x000d7;10<sup>&#x02212;3</sup>&#x02013;2.9&#x000d7;10<sup>&#x02212;3</sup>)</td><td align="center" rowspan="1" colspan="1">0.55 (0.34&#x02013;0.76)</td><td align="center" rowspan="1" colspan="1">2000 (1994&#x02013;2004)</td></tr><tr><td align="center" rowspan="1" colspan="1">B<sub>GU-II</sub></td><td align="center" rowspan="1" colspan="1">44</td><td align="center" rowspan="1" colspan="1">2010&#x02013;2013</td><td align="center" rowspan="1" colspan="1">2.4&#x000d7;10<sup>&#x02212;3</sup> (1.7&#x000d7;10<sup>&#x02212;3</sup>&#x02013;3.0&#x000d7;10<sup>&#x02212;3</sup>)</td><td align="center" rowspan="1" colspan="1">0.37 (0.004&#x02013;0.65)</td><td align="center" rowspan="1" colspan="1">2005 (2002&#x02013;2007)</td></tr><tr><td align="center" rowspan="1" colspan="1">B<sub>GU-III</sub></td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">2010&#x02013;2013</td><td align="center" rowspan="1" colspan="1">2.1&#x000d7;10<sup>&#x02212;3</sup> (1.5&#x000d7;10<sup>&#x02212;3</sup>&#x02013;2.8&#x000d7;10<sup>&#x02212;3</sup>)</td><td align="center" rowspan="1" colspan="1">0.42 (0.07&#x02013;0.75)</td><td align="center" rowspan="1" colspan="1">1991 (1980&#x02013;2000)</td></tr><tr><td align="center" rowspan="1" colspan="1">B<sub>GU-V</sub></td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">2010&#x02013;2013</td><td align="center" rowspan="1" colspan="1">2.0&#x000d7;10<sup>&#x02212;3</sup> (1.5&#x000d7;10<sup>&#x02212;3</sup>&#x02013;2.8&#x000d7;10<sup>&#x02212;3</sup>)</td><td align="center" rowspan="1" colspan="1">0.43 (0.23&#x02013;0.65)</td><td align="center" rowspan="1" colspan="1">1992 (1983&#x02013;2000)</td></tr><tr><td align="center" rowspan="1" colspan="1">B<sub>GU-VI</sub></td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">2010&#x02013;2013</td><td align="center" rowspan="1" colspan="1">2.2&#x000d7;10<sup>&#x02212;3</sup> (1.5&#x000d7;10<sup>&#x02212;3</sup>&#x02013;2.9&#x000d7;10<sup>&#x02212;3</sup>)</td><td align="center" rowspan="1" colspan="1">0.33 (0.14&#x02013;0.50)</td><td align="center" rowspan="1" colspan="1">1994 (1986&#x02013;2001)</td></tr><tr><td align="center" rowspan="1" colspan="1">B<sub>GU-VIII</sub></td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">2010&#x02013;2013</td><td align="center" rowspan="1" colspan="1">2.2&#x000d7;10<sup>&#x02212;3</sup> (1.5&#x000d7;10<sup>&#x02212;3</sup>&#x02013;2.9&#x000d7;10<sup>&#x02212;3</sup>)</td><td align="center" rowspan="1" colspan="1">0.46 (0.24&#x02013;0.68)</td><td align="center" rowspan="1" colspan="1">1994 (1986&#x02013;2001)</td></tr><tr><td align="center" rowspan="1" colspan="1">B<sub>CAM-I</sub></td><td align="center" rowspan="1" colspan="1">509</td><td align="center" rowspan="1" colspan="1">2001&#x02013;2013</td><td align="center" rowspan="1" colspan="1">2.9 &#x000d7; 10<sup>&#x02212;3</sup> (2.8&#x000d7;10<sup>&#x02212;3</sup>&#x02013;3.0&#x000d7;10<sup>&#x02212;3</sup>)</td><td align="center" rowspan="1" colspan="1">0.33 (0.29&#x02013;0.37)</td><td align="center" rowspan="1" colspan="1">1987 (1984&#x02013;1989)</td></tr><tr><td align="center" rowspan="1" colspan="1">B<sub>CAM-II</sub></td><td align="center" rowspan="1" colspan="1">224</td><td align="center" rowspan="1" colspan="1">2003&#x02013;2013</td><td align="center" rowspan="1" colspan="1">2.3 &#x000d7; 10<sup>&#x02212;3</sup> (1.7&#x000d7;10<sup>&#x02212;3</sup>&#x02013;2.9&#x000d7;10<sup>&#x02212;3</sup>)</td><td align="center" rowspan="1" colspan="1">0.21 (0.14&#x02013;0.28)</td><td align="center" rowspan="1" colspan="1">1978 (1968&#x02013;1986)</td></tr><tr><td align="center" rowspan="1" colspan="1">B<sub>CAM-III</sub></td><td align="center" rowspan="1" colspan="1">150</td><td align="center" rowspan="1" colspan="1">2001&#x02013;2013</td><td align="center" rowspan="1" colspan="1">2.9 &#x000d7; 10<sup>&#x02212;3</sup> (2.7&#x000d7;10<sup>&#x02212;3</sup>&#x02013;3.0&#x000d7;10<sup>&#x02212;3</sup>)</td><td align="center" rowspan="1" colspan="1">0.31 (0.22&#x02013;0.41)</td><td align="center" rowspan="1" colspan="1">1987 (1984&#x02013;1990)</td></tr><tr><td align="center" rowspan="1" colspan="1">B<sub>CAM-IV</sub></td><td align="center" rowspan="1" colspan="1">126</td><td align="center" rowspan="1" colspan="1">2005&#x02013;2013</td><td align="center" rowspan="1" colspan="1">1.9&#x000d7;10<sup>&#x02212;3</sup> (1.5&#x000d7;10<sup>&#x02212;3</sup>&#x02013;2.6&#x000d7;10<sup>&#x02212;3</sup>)</td><td align="center" rowspan="1" colspan="1">0.30 (0.22&#x02013;0.39)</td><td align="center" rowspan="1" colspan="1">1980 (1971&#x02013;1990)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p><sup>a</sup>95% Higher Posterior Density intervals are shown in parentheses.</p></fn></table-wrap-foot></table-wrap><p>The root location of Central American clades B<sub>CAM-I</sub> and B<sub>CAM-III</sub> was most probably traced to Honduras (Posterior State Probability, <italic>PSP</italic> &#x02265;0.99) around the middle 1980s (<xref rid="pone.0203916.t002" ref-type="table">Table 2</xref>). The most widely disseminated viral clade, B<sub>CAM-I,</sub> migrated from Honduras to the department of Guatemala, El Salvador and Mexico during the early 1990s and later moved to other Guatemalan departments around 2010 (<xref ref-type="fig" rid="pone.0203916.g005">Fig 5</xref>). From the department of Guatemala, clade B<sub>CAM-I</sub> was disseminated to other 16 Guatemalan departments and also to Mexico, Belize, and back to Honduras. El Salvador and the Guatemalan department of Escuintla were also secondary hubs of dissemination of clade B<sub>CAM-I</sub>. Clade B<sub>CAM-III</sub> moved from Honduras to several Guatemalan departments (Guatemala, Zacapa, Sacatep&#x000e9;quez, Izabal and Chiquimula) and to Mexico since 1997 (<xref ref-type="fig" rid="pone.0203916.g005">Fig 5</xref>). The department of Guatemala acted as a secondary hub of dissemination of B<sub>CAM-III</sub> sending viruses to other Guatemalan departments from 2001 onwards.</p><fig id="pone.0203916.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0203916.g005</object-id><label>Fig 5</label><caption><title>Spatial dissemination of HIV-1 Central American clades circulating in Guatemala (B<sub>CAM-I</sub> to B<sub>CAM-IV</sub>).</title><p>Lines between departments and neighboring countries represent branches in the Bayesian MCC tree along which location transitions occur. Lines were colored according to the source location as indicated in the legend at the bottom. Dashed lines indicate transitions associated to nodes with low location probability support (&#x0003c;0.60). Countries: Belize (BZ), El Salvador (SV), Mexico (MX) and Honduras (HN). Guatemalan Departments: Alta Verapaz (AV), Baja Verapaz (BV), Chimaltenango (CM), Chiquimula (CQ), El Progreso (PR), Escuintla (ES), Guatemala (GU), Huehuelenango (HU), IZABAL (IZ), Jalapa (JA), Jutiapa (JU), PETEN (PE), Quetzaltenango (QT), Quiche (QC), Retalhuleu (RE), Sacatepequez (SA), San Marcos (SM), Santa Rosa (SR), Solola (SO), Suchitepequez (SU), Totonicapan (TO) and Zacapa (ZA).</p></caption><graphic xlink:href="pone.0203916.g005"/></fig><p>The root location for clades B<sub>CAM-II</sub> and B<sub>CAM-IV</sub> was most probably traced to the department of Guatemala (<italic>PSP</italic> = 0.47 and 0.99, respectively) between the late 1970s and the early 1990s (<xref rid="pone.0203916.t002" ref-type="table">Table 2</xref>). Clade B<sub>CAM-II</sub> moved from the department of Guatemala to Honduras and El Salvador around the late 1970s, to the Guatemalan departments of Solola and Chiquimula during the 1990s, and to other 11 Guatemalan departments, Belize and Mexico since the early 2000 (<xref ref-type="fig" rid="pone.0203916.g005">Fig 5</xref>). Secondary hubs of dissemination of clade B<sub>CAM-II</sub> were El Salvador from where the virus has spread to Honduras, back to the department of Guatemala, and to other seven Guatemalan departments since the early 1990s, and Honduras from where the virus has spread back to the department of Guatemala and Mexico since the early 1980s. The department of Guatemala was the major epicenter of clade B<sub>CAM-IV</sub> moving from the capital to other 15 Guatemalan departments, as well as to El Salvador and Mexico since the middle 1980s. From El Salvador, clade B<sub>CAM-IV</sub> moved back to the department of Guatemala.</p></sec><sec id="sec016"><title>Demographic history of major HIV-1 subtype B clades circulating in Guatemala</title><p>To reconstruct the population dynamics of the HIV-1 subtype B epidemic in Guatemala, we used the Guatemalan sequences from those clades that arose in Guatemala (B<sub>GU-I</sub>, B<sub>GU-II</sub>, B<sub>GU-III</sub>, B<sub>GU-V</sub>, B<sub>GU-VI</sub> and B<sub>GU-VIII</sub>, and B<sub>CAM-IV</sub>) and well supported (aLTR &#x02265;80) Guatemala-specific sub-clades within clades B<sub>CAM-I</sub> (B<sub>CAM-I/GU-I</sub> = 51 sequences and B<sub>CAM-I/GU-II</sub> = 37) and B<sub>CAM-III</sub> (B<sub>CAM-III/GU</sub> = 71 sequences). Bayesian skyline plot (BSP) analyses suggest that most clades experienced an initial phase of exponential growth followed by a decline in growth rate during the 2000s, leading to stabilization of the effective population size (Ne) (<xref ref-type="fig" rid="pone.0203916.g006">Fig 6</xref>). Some clades (B<sub>GU-II</sub>, B<sub>GU-III</sub>, B<sub>CAM-IV</sub> and B<sub>CAM-I/GU-II</sub>), however, seem to have experienced more complex dynamics characterized by phases of expansion interleaved by periods of slow growth (<xref ref-type="fig" rid="pone.0203916.g006">Fig 6</xref>). Model comparison indicated that the best-fit demographic model was the logistic for clades B<sub>GU-II,</sub> B<sub>CAM-IV,</sub> B<sub>GU-VI</sub>, B<sub>CAM-I/GU-I</sub> and B<sub>CAM-I/GU-II</sub>, while both the logistic and exponential models fit equally well the demographic signal in clades B<sub>GU-I,</sub> B<sub>GU-III,</sub> B<sub>GU-V</sub>, B<sub>GU-VIII</sub> and B<sub>GU-IX</sub> (<xref ref-type="supplementary-material" rid="pone.0203916.s004">S3 Table</xref>). According to these parametric models, the mean estimated growth rate of major clades circulating in Guatemala ranged from 0.23 year<sup>-1</sup> for clade B<sub>GU-III</sub> to 3.59 year<sup>-1</sup> for clade B<sub>GU-II</sub> (<xref rid="pone.0203916.t003" ref-type="table">Table 3</xref>).</p><fig id="pone.0203916.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0203916.g006</object-id><label>Fig 6</label><caption><title>Demographic history of HIV-1 Guatemalan clades.</title><p>Effective number of infections per year was estimated using a Bayesian skyline growth coalescent model for each one of the Guatemalan clades. Median estimates of the effective number of infections (solid line) and 95% High Posterior Density intervals of the estimates (dashed lines) are shown.</p></caption><graphic xlink:href="pone.0203916.g006"/></fig><table-wrap id="pone.0203916.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0203916.t003</object-id><label>Table 3</label><caption><title>Population dynamics estimates for Guatemalan HIV-1 subtype B clades.</title></caption><alternatives><graphic id="pone.0203916.t003g" xlink:href="pone.0203916.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Clade</th><th align="center" rowspan="1" colspan="1">Demographic model</th><th align="center" rowspan="1" colspan="1"><italic>T</italic><sub>MRCA</sub><xref ref-type="table-fn" rid="t003fn001"><sup>a</sup></xref></th><th align="center" rowspan="1" colspan="1">Growth rate (yr<sup>-1</sup>)<xref ref-type="table-fn" rid="t003fn001"><sup>a</sup></xref></th></tr></thead><tbody><tr><td align="center" rowspan="2" colspan="1">B<sub>GU-I</sub></td><td align="center" rowspan="1" colspan="1">Exponential</td><td align="center" rowspan="1" colspan="1">2000 (1995&#x02013;2004)</td><td align="center" rowspan="1" colspan="1">0.58 (0.36&#x02013;0.82)</td></tr><tr><td align="center" rowspan="1" colspan="1">Logistic</td><td align="center" rowspan="1" colspan="1">2000 (1996&#x02013;2005)</td><td align="center" rowspan="1" colspan="1">0.70 (0.39&#x02013;1.11)</td></tr><tr><td align="center" rowspan="2" colspan="1">B<sub>GU-II</sub></td><td align="center" rowspan="1" colspan="1">Logistic</td><td align="center" rowspan="1" colspan="1">2005 (2002&#x02013;2007)</td><td align="center" rowspan="1" colspan="1">3.59 (0.30&#x02013;9.02)</td></tr><tr><td align="center" rowspan="1" colspan="1">Exponential</td><td align="center" rowspan="1" colspan="1">2004 (2000&#x02013;2007)</td><td align="center" rowspan="1" colspan="1">0.41 (0.19&#x02013;0.66)</td></tr><tr><td align="center" rowspan="2" colspan="1">B<sub>GU-III</sub></td><td align="center" rowspan="1" colspan="1">Exponential</td><td align="center" rowspan="1" colspan="1">1993 (1983&#x02013;2001)</td><td align="center" rowspan="1" colspan="1">0.24 (0.10&#x02013;0.42)</td></tr><tr><td align="center" rowspan="1" colspan="1">Logistic</td><td align="center" rowspan="1" colspan="1">1992 (1982&#x02013;2001)</td><td align="center" rowspan="1" colspan="1">0.23 (0.00&#x02013;2.34)</td></tr><tr><td align="center" rowspan="2" colspan="1">B<sub>GU-V</sub></td><td align="center" rowspan="1" colspan="1">Exponential</td><td align="center" rowspan="1" colspan="1">1993 (1985&#x02013;2000)</td><td align="center" rowspan="1" colspan="1">0.33 (0.21&#x02013;0.52)</td></tr><tr><td align="center" rowspan="1" colspan="1">Logistic</td><td align="center" rowspan="1" colspan="1">1993 (1986&#x02013;2000)</td><td align="center" rowspan="1" colspan="1">0.43 (0.21&#x02013;0.76)</td></tr><tr><td align="center" rowspan="1" colspan="1">B<sub>GU-VI</sub></td><td align="center" rowspan="1" colspan="1">Logistic</td><td align="center" rowspan="1" colspan="1">1996 (1996&#x02013;2001)</td><td align="center" rowspan="1" colspan="1">0.99 (0.48&#x02013;1.72)</td></tr><tr><td align="center" rowspan="2" colspan="1">B<sub>GU-VIII</sub></td><td align="center" rowspan="1" colspan="1">Exponential</td><td align="center" rowspan="1" colspan="1">1995 (1987&#x02013;2001)</td><td align="center" rowspan="1" colspan="1">0.36 (0.19&#x02013;0.54)</td></tr><tr><td align="center" rowspan="1" colspan="1">Logistic</td><td align="center" rowspan="1" colspan="1">1995 (1987&#x02013;2001)</td><td align="center" rowspan="1" colspan="1">0.38 (0.13&#x02013;0.68)</td></tr><tr><td align="center" rowspan="1" colspan="1">B<sub>CAM-I/GU-A</sub></td><td align="center" rowspan="1" colspan="1">Logistic</td><td align="center" rowspan="1" colspan="1">1998 (1993&#x02013;2003)</td><td align="center" rowspan="1" colspan="1">1.46 (0.52&#x02013;3.00)</td></tr><tr><td align="center" rowspan="1" colspan="1">B<sub>CAM-I/GU-B</sub></td><td align="center" rowspan="1" colspan="1">Logistic</td><td align="center" rowspan="1" colspan="1">1997 (1991&#x02013;2002)</td><td align="center" rowspan="1" colspan="1">2.09 (0.61&#x02013;5.03)</td></tr><tr><td align="center" rowspan="1" colspan="1">B<sub>CAM-III/GU</sub></td><td align="center" rowspan="1" colspan="1">Logistic</td><td align="center" rowspan="1" colspan="1">1997 (1990&#x02013;2001)</td><td align="center" rowspan="1" colspan="1">0.68 (0.35&#x02013;1.12)</td></tr><tr><td align="center" rowspan="1" colspan="1">B<sub>CAM-IV/GU</sub></td><td align="center" rowspan="1" colspan="1">Logistic</td><td align="center" rowspan="1" colspan="1">1984 (1975&#x02013;1994)</td><td align="center" rowspan="1" colspan="1">0.40 (0.26&#x02013;0.63)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p><sup>a</sup>95% Higher Posterior Density intervals are shown in parentheses.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="conclusions" id="sec017"><title>Discussion</title><p>The HIV-1 subtype B epidemic in Guatemala is mostly related to the B<sub>PANDEMIC</sub> clade (98.9%), as described for the majority of the Central [<xref rid="pone.0203916.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0203916.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0203916.ref036" ref-type="bibr">36</xref>], North, and South [<xref rid="pone.0203916.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0203916.ref037" ref-type="bibr">37</xref>] American countries. The proportion of Guatemalan HIV-1 subtype B viruses belonging to the B<sub>CAR</sub> clades (1.1%) was similar to the prevalence reported for Honduras, El Salvador, and Mexico (&#x0003c;1.1%) [<xref rid="pone.0203916.ref037" ref-type="bibr">37</xref>], but lower than the one reported in Panama (5.5%), the country where B<sub>CAR</sub> clade circulation was first demonstrated in Central America [<xref rid="pone.0203916.ref008" ref-type="bibr">8</xref>].</p><p>Our phylogeographic analysis identified both country- and region-specific HIV-1 subtype B clades involved in the Guatemalan HIV epidemic, contrasting with the Panamanian epidemic characterized mostly by the dissemination of country-specific clades [<xref rid="pone.0203916.ref008" ref-type="bibr">8</xref>]<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Uribe-Salas%20F%5BAuthor%5D&#x00026;cauthor=true&#x00026;cauthor_uid=12616149">http://www.ncbi.nlm.nih.gov/pubmed/?term=Uribe-Salas%20F%5BAuthor%5D&#x00026;cauthor=true&#x00026;cauthor_uid=12616149</ext-link>. Our study further reveals the existence of at least four major regional-specific clades in Central America (BCAM-I&#x02014;B<sub>CAM-IV</sub>), contrasting with the previous observation of a single HIV subtype B linage (B<sub>CAM</sub> clade) accounting for most of the HIV epidemic burden in Central America [<xref rid="pone.0203916.ref007" ref-type="bibr">7</xref>]. The fact that the Central American clades BCAM-I&#x02014;B<sub>CAM-IV</sub> differ in root location (B<sub>CAM-I</sub> and B<sub>CAM-III</sub> traced to Honduras, and B<sub>CAM-II</sub> and B<sub>CAM-IV</sub> traced to Guatemala), also refute the Murillo <italic>et al</italic> assertion that a single viral introduction event was responsible for most of the HIV-1 subtype B infections in Central America. This change in the previously described HIV-1 epidemiological history of subtype B in Central America is expected, considering the fact that the highest number of individuals estimated to be living with HIV in Central America are from Guatemala [<xref rid="pone.0203916.ref009" ref-type="bibr">9</xref>], and this country was not included in previous analyses.</p><p>Nearly half of all Guatemalan HIV-1 subtype B sequences included in our study branched within Central American B<sub>PANDEMIC</sub> clades (67%), indicating an unrestricted viral flow between main transmission networks from Guatemala and the neighboring Central American countries of Honduras and El Salvador. This result is consistent with a previous study that suggested an HIV-1 subtype B epidemiological link between the Guatemalan neighboring countries Belize, Honduras and El Salvador [<xref rid="pone.0203916.ref006" ref-type="bibr">6</xref>]. A much more restricted viral flow, by contrast, was observed between Guatemala and Mexico (despite their close geographic proximity) and between Guatemala and Panama. Viral flux between Guatemala and Belize, Nicaragua and Costa Rica was not possible to estimate because of the paucity of HIV-1 <italic>pol</italic> sequences from these countries.</p><p>About one fourth of all Guatemalan HIV-1 subtype B sequences included in our study branched within six country-specific clades of large size (B<sub>GU-I</sub>, B<sub>GU-II</sub>, B<sub>GU-III,</sub> B<sub>GU-V</sub>, B<sub>GU-VI</sub>, and B<sub>GU-VIII</sub>). The analysis of clinical and demographic characteristics, however, reveals no major difference between B<sub>CAM</sub> and B<sub>GU</sub> clades, with the exception of clade B<sub>GU-II</sub> that differed from all other clades mostly comprising mainly young, recently infected MSM with higher education and employment rates. In the last 10 years, HIV prevalence among MSM has remained higher than 8% in Guatemala, with most of the cases (75%) related to MSM younger than 36 years with higher education [<xref rid="pone.0203916.ref038" ref-type="bibr">38</xref>]. Major differences, by contrast, were detected between B<sub>CAM</sub> and B<sub>GU</sub> clades, with regards to the estimated origin of the different lineages: B<sub>GU</sub> clades displayed a much more recent median T<sub>MRCA</sub> (between the 1990s and 2000s) than the B<sub>CAM</sub> clades (between the 1970s and 1980s), which may have had a great impact in the geographical expansion of each lineage.</p><p>The spatiotemporal dissemination analysis of B<sub>GU</sub> and B<sub>CAM</sub> clades evidenced complex migration patterns characterizing the HIV-1 epidemic in the region, involving Guatemalan departments and the neighboring countries Honduras, El Salvador, Belize and Mexico. Guatemalan internal and external migration has been attributed mostly to economic factors, with population mobility from poor rural areas to agriculture or industrial developing areas [<xref rid="pone.0203916.ref039" ref-type="bibr">39</xref>], and the country&#x02019;s civil war that lasted 32 years, from 1960 to 1996 [<xref rid="pone.0203916.ref040" ref-type="bibr">40</xref>]. The department of Guatemala and, to a lesser extent, Escuintla, Izabal and Pet&#x000e9;n have been the main destinations for internal-migration from the eastern and western departments of the country, with dynamic bidirectional population mobility [<xref rid="pone.0203916.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0203916.ref042" ref-type="bibr">42</xref>]. Regarding external migration, 50% of immigrants to Guatemala correspond to people of other Central American countries, mostly from El Salvador, Nicaragua and Honduras [<xref rid="pone.0203916.ref042" ref-type="bibr">42</xref>], yet the Guatemalan net migration rate is negative [<xref rid="pone.0203916.ref043" ref-type="bibr">43</xref>] with emigration flows mostly to the United States of America, and the neighboring countries of Mexico, Honduras, El Salvador and Belize [<xref rid="pone.0203916.ref042" ref-type="bibr">42</xref>]. Our phylogeographic reconstructions revealed that the department of Guatemala was the dissemination epicenter of the B<sub>GU</sub>, B<sub>CAM-II</sub> and B<sub>CAM-IV</sub> clades to the rest of Guatemalan departments and to the Guatemalan neighboring countries. Additionally, the departments of Guatemala and Escuintla served as secondary hubs of dissemination of the B<sub>CAM-I</sub> and B<sub>CAM-III</sub> clades, which emerged in Honduras, to other Guatemalan departments and to the four bordering countries in the case of B<sub>CAM-I</sub>. The estimated T<sub>MRCA</sub> of B<sub>GU</sub> clades, ranging between the early 1990s and the middle 2000s, also coincides with an increased repatriation and deportation rate of Guatemalans from Mexico and the United States of America, respectively [<xref rid="pone.0203916.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0203916.ref044" ref-type="bibr">44</xref>], although we found no significant evolutionary links between B<sub>GU</sub> clades and the Mexican subtype B epidemic.</p><p>The demographic analysis of the B<sub>GU-I</sub>, B<sub>GU-V</sub>, B<sub>GU-VI</sub>, B<sub>GU-VIII</sub>, and B<sub>CAM-I/GU-I</sub> clusters suggested that, even though all these clades had an initial phase of exponential growth, the dissemination of these clades declined during the 2000s. On the other hand, the B<sub>GU-II</sub>, B<sub>GU-III</sub>, B<sub>CAM-IV</sub> and B<sub>CAM-I/GU-II</sub> clades evidenced a more complex growth dynamics with phases of expansion interleaved by periods of slow growth. The B<sub>GU-II</sub> clade, characterized mostly by a population of young MSM, evidenced the highest mean estimated logistic growth rate (3.6 year<sup>-1</sup>) among the major clades circulating in Guatemala. The B<sub>GU-II</sub> clade growth rate was remarkably higher than those previously estimated for other country-specific B clades mainly or exclusively restricted to MSM (ranging from 0.5 to 1.6 year<sup>-1</sup>) [<xref rid="pone.0203916.ref045" ref-type="bibr">45</xref>&#x02013;<xref rid="pone.0203916.ref048" ref-type="bibr">48</xref>]. Furthermore, the proportion of strains that corresponds to new infections within the B<sub>GU-II</sub> clade was higher (59.1%) compared with the rest of the B<sub>GU</sub> and B<sub>CAM</sub> clades (ranging from 6.9% of B<sub>GU-III</sub> to 22.1% of B<sub>CAM-III</sub>). As the HIV epidemic in Guatemala is concentrated in high-risk key populations, with 8.9% prevalence in MSM [<xref rid="pone.0203916.ref010" ref-type="bibr">10</xref>], an increase in size and proportion of the B<sub>GU-II</sub> clade would be expected in the current Guatemalan HIV epidemic. These results, however, should be interpreted with caution because the exponential growth model, that was equally supported as the logistic one, showed a much lower mean growth rate (0.4 year<sup>-1</sup>) for the B<sub>GU-II</sub> clade. Despite the fact that other major subtype B clades in Guatemala mostly circulate among individuals infected by the same transmission route (heterosexual transmission), the mean estimated growth rate of these lineages varied considerably, ranging from 0.2 year<sup>-1</sup> for clade B<sub>GU-III</sub> to 2.1 year<sup>-1</sup> for clade B<sub>CAM-I/GU-II</sub>. This range is even higher than that estimated for country-specific B<sub>PANDEMIC</sub> clades circulating in the general population in different Latin American countries (0.2&#x02013;0.9 year<sup>-1</sup>) [<xref rid="pone.0203916.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0203916.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0203916.ref036" ref-type="bibr">36</xref>].</p><p>It is important to acknowledge some limitations of our study design. Even when the study sample size is large, sequences were obtained from a single HIV clinic. Additionally, the time frame for collecting HIV sequences was limited (2010&#x02013;2013). Nevertheless, the Roosevelt Hospital is the largest of a total of 18 HIV clinics in the country, providing antiretroviral treatment for 30% of all registered HIV-infected persons in Guatemala [<xref rid="pone.0203916.ref015" ref-type="bibr">15</xref>], and the demographic characteristics (including female-to-male ratio, mean age, race, marital status, literacy) and geographical distribution of persons attending this clinic are highly representative of the whole population living with HIV in Guatemala [<xref rid="pone.0203916.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0203916.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0203916.ref017" ref-type="bibr">17</xref>]. Indeed, among the Roosevelt Hospital&#x02019;s clients, 45% reside outside the department of Guatemala [<xref rid="pone.0203916.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0203916.ref016" ref-type="bibr">16</xref>]. Our study group is highly representative of the Roosevelt Hospital cohort, as more than 80% of all adults diagnosed at this clinic during the enrolment period were included in the study (expecting approximately 450 total new cases per year [<xref rid="pone.0203916.ref016" ref-type="bibr">16</xref>]). Given these characteristics of the Roosevelt Hospital&#x02019;s cohort, we would not expect our main observations to vary significantly if additional participants enrolled in clinics from around the country were to be included.</p></sec><sec sec-type="conclusions" id="sec018"><title>Conclusions</title><p>In summary, our observations suggest that the Guatemalan HIV-1 subtype B epidemic is being driven by dissemination of multiple B<sub>PANDEMIC</sub> founder viral strains, some of them mostly restricted to Guatemala and others widely disseminated in the Central American region. Moreover, our results identify Guatemala and Honduras as hubs that have played a central role in dissemination of B<sub>PANDEMIC</sub> viral strains within Central America and further suggest the existence of different sub-epidemics with distinct evolutionary and demographic dynamics within Guatemala and for which different targeted prevention efforts might be needed.</p></sec><sec sec-type="supplementary-material" id="sec019"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0203916.s001"><label>S1 Data</label><caption><title>Selected HIV-1 subtype B PR-RT sequences.</title><p>Fasta HIV-1 subtype B PR-RT Guatemalan sequences included in the study.</p><p>(TXT)</p></caption><media xlink:href="pone.0203916.s001.txt"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0203916.s002"><label>S1 Table</label><caption><title>Origin and sampling interval of HIV-1 subtype B sequences.</title><p>(DOCX)</p></caption><media xlink:href="pone.0203916.s002.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0203916.s003"><label>S2 Table</label><caption><title>Distribution of HIV-1 subtype B sequences of Central American countries in Guatemalan B<sub>CAM</sub> clades.</title><p>(DOCX)</p></caption><media xlink:href="pone.0203916.s003.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0203916.s004"><label>S3 Table</label><caption><title>Best fit demographic model for the major HIV-1 Guatemalan clades.</title><p>Log marginal likelihood (ML) estimates for the logistic (Log), exponential (Expo) and expansion (Expa) growth demographic models obtained using the path sampling (PS) and stepping-stone sampling (SS) methods. The Log Bayes factor (BF) is the difference of the Log ML between of alternative (H1) and null (H0) models (H1/H0). Log BFs &#x0003e; 3 indicates that model H1 is more strongly supported by the data than model H0.</p><p>(DOCX)</p></caption><media xlink:href="pone.0203916.s004.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>This work was supported by grants from the Mexican Government (Comisi&#x000f3;n de Equidad y G&#x000e9;nero de las Legislaturas LX-LXI y Comisi&#x000f3;n de Igualdad de G&#x000e9;nero de la Legislatura LXII de la H. C&#x000e1;mara de Diputados de la Rep&#x000fa;blica Mexicana), received by GRT, and Consejo Nacional de Ciencia y Tecnolog&#x000ed;a (CONACyT SALUD-2013-01-202475; <ext-link ext-link-type="uri" xlink:href="http://www.conacyt.mx/">http://www.conacyt.mx</ext-link>), received by SAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></ack><ref-list><title>References</title><ref id="pone.0203916.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Gilbert</surname><given-names>MT</given-names></name>, <name><surname>Rambaut</surname><given-names>A</given-names></name>, <name><surname>Wlasiuk</surname><given-names>G</given-names></name>, <name><surname>Spira</surname><given-names>TJ</given-names></name>, <name><surname>Pitchenik</surname><given-names>AE</given-names></name>, <name><surname>Worobey</surname><given-names>M</given-names></name>. <article-title>The emergence of HIV/AIDS in the Americas and beyond</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2007</year>;<volume>104</volume>(<issue>47</issue>):<fpage>18566</fpage>&#x02013;<lpage>70</lpage>. Epub 2007/11/06. <pub-id pub-id-type="doi">10.1073/pnas.0705329104</pub-id> ; PubMed Central PMCID: PMC2141817.<?supplied-pmid 17978186?><pub-id pub-id-type="pmid">17978186</pub-id></mixed-citation></ref><ref id="pone.0203916.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Nadai</surname><given-names>Y</given-names></name>, <name><surname>Eyzaguirre</surname><given-names>LM</given-names></name>, <name><surname>Sill</surname><given-names>A</given-names></name>, <name><surname>Cleghorn</surname><given-names>F</given-names></name>, <name><surname>Nolte</surname><given-names>C</given-names></name>, <name><surname>Charurat</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>HIV-1 epidemic in the Caribbean is dominated by subtype B</article-title>. <source>PloS one</source>. <year>2009</year>;<volume>4</volume>(<issue>3</issue>):<fpage>e4814</fpage> Epub 2009/03/13. <pub-id pub-id-type="doi">10.1371/journal.pone.0004814</pub-id> ; PubMed Central PMCID: PMC2652827.<?supplied-pmid 19279683?><pub-id pub-id-type="pmid">19279683</pub-id></mixed-citation></ref><ref id="pone.0203916.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Cabello</surname><given-names>M</given-names></name>, <name><surname>Mendoza</surname><given-names>Y</given-names></name>, <name><surname>Bello</surname><given-names>G</given-names></name>. <article-title>Spatiotemporal dynamics of dissemination of non-pandemic HIV-1 subtype B clades in the Caribbean region</article-title>. <source>PloS one</source>. <year>2014</year>;<volume>9</volume>(<issue>8</issue>):<fpage>e106045</fpage> Epub 2014/08/26. <pub-id pub-id-type="doi">10.1371/journal.pone.0106045</pub-id> ; PubMed Central PMCID: PMC4141835.<?supplied-pmid 25148215?><pub-id pub-id-type="pmid">25148215</pub-id></mixed-citation></ref><ref id="pone.0203916.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Paraskevis</surname><given-names>D</given-names></name>, <name><surname>Pybus</surname><given-names>O</given-names></name>, <name><surname>Magiorkinis</surname><given-names>G</given-names></name>, <name><surname>Hatzakis</surname><given-names>A</given-names></name>, <name><surname>Wensing</surname><given-names>AM</given-names></name>, <name><surname>van de Vijver</surname><given-names>DA</given-names></name>, <etal>et al</etal>
<article-title>Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach</article-title>. <source>Retrovirology</source>. <year>2009</year>;<volume>6</volume>:<fpage>49</fpage> Epub 2009/05/22. <pub-id pub-id-type="doi">10.1186/1742-4690-6-49</pub-id> ; PubMed Central PMCID: PMC2717046.<?supplied-pmid 19457244?><pub-id pub-id-type="pmid">19457244</pub-id></mixed-citation></ref><ref id="pone.0203916.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Junqueira</surname><given-names>DM</given-names></name>, <name><surname>de Medeiros</surname><given-names>RM</given-names></name>, <name><surname>Matte</surname><given-names>MC</given-names></name>, <name><surname>Araujo</surname><given-names>LA</given-names></name>, <name><surname>Chies</surname><given-names>JA</given-names></name>, <name><surname>Ashton-Prolla</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Reviewing the history of HIV-1: spread of subtype B in the Americas</article-title>. <source>PloS one</source>. <year>2011</year>;<volume>6</volume>(<issue>11</issue>):<fpage>e27489</fpage> Epub 2011/12/02. <pub-id pub-id-type="doi">10.1371/journal.pone.0027489</pub-id> ; PubMed Central PMCID: PMC3223166.<?supplied-pmid 22132104?><pub-id pub-id-type="pmid">22132104</pub-id></mixed-citation></ref><ref id="pone.0203916.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Pagan</surname><given-names>I</given-names></name>, <name><surname>Holguin</surname><given-names>A</given-names></name>. <article-title>Reconstructing the Timing and Dispersion Routes of HIV-1 Subtype B Epidemics in The Caribbean and Central America: A Phylogenetic Story</article-title>. <source>PloS one</source>. <year>2013</year>;<volume>8</volume>(<issue>7</issue>):<fpage>e69218</fpage> Epub 2013/07/23. <pub-id pub-id-type="doi">10.1371/journal.pone.0069218</pub-id> .<?supplied-pmid 23874917?><pub-id pub-id-type="pmid">23874917</pub-id></mixed-citation></ref><ref id="pone.0203916.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Murillo</surname><given-names>W</given-names></name>, <name><surname>Veras</surname><given-names>N</given-names></name>, <name><surname>Prosperi</surname><given-names>M</given-names></name>, <name><surname>Lorenzana de Rivera</surname><given-names>I</given-names></name>, <name><surname>Paz-Bailey</surname><given-names>G</given-names></name>, <name><surname>Morales-Miranda</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>A single early introduction of HIV-1 subtype B into Central America accounts for most current cases</article-title>. <source>Journal of virology</source>. <year>2013</year>; <volume>87</volume>(<issue>13</issue>):<fpage>7463</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01602-12</pub-id>
<?supplied-pmid 23616665?><pub-id pub-id-type="pmid">23616665</pub-id></mixed-citation></ref><ref id="pone.0203916.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Mendoza</surname><given-names>Y</given-names></name>, <name><surname>Martinez</surname><given-names>AA</given-names></name>, <name><surname>Castillo Mewa</surname><given-names>J</given-names></name>, <name><surname>Gonzalez</surname><given-names>C</given-names></name>, <name><surname>Garcia-Morales</surname><given-names>C</given-names></name>, <name><surname>Avila-Rios</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Human Immunodeficiency Virus Type 1 (HIV-1) Subtype B Epidemic in Panama Is Mainly Driven by Dissemination of Country-Specific Clades</article-title>. <source>PloS one</source>. <year>2014</year>;<volume>9</volume>(<issue>4</issue>):<fpage>e95360</fpage> Epub 2014/04/22. <pub-id pub-id-type="doi">10.1371/journal.pone.0095360</pub-id> ; PubMed Central PMCID: PMC3991702.<?supplied-pmid 24748274?><pub-id pub-id-type="pmid">24748274</pub-id></mixed-citation></ref><ref id="pone.0203916.ref009"><label>9</label><mixed-citation publication-type="book"><collab>UNAIDS</collab>. <chapter-title>How AIDS changed everything&#x02014;MDG6: 15 years, 15 lessons of hope from the AIDS response</chapter-title>
<publisher-loc>Switzerland</publisher-loc>: <publisher-name>Joint United Nations Programme on HIV/AIDS</publisher-name>; <year>2015</year>. p. ISBN: 978-92-9253-069-3.</mixed-citation></ref><ref id="pone.0203916.ref010"><label>10</label><mixed-citation publication-type="other">Guatemala: evaluaci&#x000f3;n final del plan estrat&#x000e9;gico nacional para la prevenci&#x000f3;n, atenci&#x000f3;n y control de ITS, VIH y SIDA, 2011&#x02013;2015. Gobierno de Guatemala. Ministerio de Salud P&#x000fa;blica y Asistencia Social.; 2015.</mixed-citation></ref><ref id="pone.0203916.ref011"><label>11</label><mixed-citation publication-type="book"><name><surname>Garcia</surname><given-names>J.</given-names></name>
<chapter-title>Vigilancia Epidemiol&#x000f3;gica del VIH, Guatemala 2017</chapter-title>
<publisher-name>Ministerio de Salud P&#x000fa;blica y Asistencia Social, Departamento de Epidemiolog&#x000ed;a</publisher-name>
<year>2017</year> Available from: <ext-link ext-link-type="uri" xlink:href="http://epidemiologia.mspas.gob.gt/files/Publicaciones2017/VIH/VIHaJunio2017JGrealizadaenagosto2017.pdf">http://epidemiologia.mspas.gob.gt/files/Publicaciones2017/VIH/VIHaJunio2017JGrealizadaenagosto2017.pdf</ext-link>.</mixed-citation></ref><ref id="pone.0203916.ref012"><label>12</label><mixed-citation publication-type="other">Informe Nacional sobre los Progresos Realizados en la Lucha Contra el VIH y sida. Ministerio de Salud P&#x000fa;lica y Asistencia Social. Programa Nacional de Prevenci&#x000f3;n y Control de ITS/VIH/SIDA2014.</mixed-citation></ref><ref id="pone.0203916.ref013"><label>13</label><mixed-citation publication-type="book"><collab>WHO</collab>. <chapter-title>Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection</chapter-title>
<publisher-name>Recommendations for a Public Health Approach</publisher-name>
<edition>Second Edition</edition>
<year>2016</year> Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/handle/10665/208825/9789241549684_eng.pdf;jsessionid=04F13FC7759D72D44ED6AC6B2E5433F5?sequence=1">http://apps.who.int/iris/bitstream/handle/10665/208825/9789241549684_eng.pdf;jsessionid=04F13FC7759D72D44ED6AC6B2E5433F5?sequence=1</ext-link>.</mixed-citation></ref><ref id="pone.0203916.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Avila-Rios</surname><given-names>S</given-names></name>, <name><surname>Garcia-Morales</surname><given-names>C</given-names></name>, <name><surname>Garrido-Rodriguez</surname><given-names>D</given-names></name>, <name><surname>Tapia-Trejo</surname><given-names>D</given-names></name>, <name><surname>Giron-Callejas</surname><given-names>AC</given-names></name>, <name><surname>Mendizabal-Burastero</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>HIV-1 drug resistance surveillance in antiretroviral treatment-naive individuals from a reference hospital in Guatemala, 2010&#x02013;2013</article-title>. <source>AIDS research and human retroviruses</source>. <year>2015</year>;<volume>31</volume>(<issue>4</issue>):<fpage>401</fpage>&#x02013;<lpage>11</lpage>. Epub 2014/10/28. <pub-id pub-id-type="doi">10.1089/aid.2014.0057</pub-id> .<?supplied-pmid 25347163?><pub-id pub-id-type="pmid">25347163</pub-id></mixed-citation></ref><ref id="pone.0203916.ref015"><label>15</label><mixed-citation publication-type="book"><collab>MSPAS</collab>. <source>Informe Nacional de la Cascada del Continuo de Atenci&#x000f3;n en VIH, medici&#x000f3;n del indicador de sobrevida, Guatemala, 2015</source>. <publisher-name>Ministerio de Salud P&#x000fa;blica y Asistencia Social de Guatemala</publisher-name>
<year>2017</year> Available from: <ext-link ext-link-type="uri" xlink:href="http://www.pasca.org/userfiles/InformeCascadadelContinuodeAtenci&#x000f3;nenVIHGuatemala2015.pdf">http://www.pasca.org/userfiles/InformeCascadadelContinuodeAtenci&#x000f3;nenVIHGuatemala2015.pdf</ext-link>.</mixed-citation></ref><ref id="pone.0203916.ref016"><label>16</label><mixed-citation publication-type="book"><name><surname>Giron-Callejas</surname><given-names>AC</given-names></name>, <name><surname>Mendizabal-Burastero</surname><given-names>R</given-names></name>, <name><surname>Garc&#x000ed;a</surname><given-names>L</given-names></name>, <name><surname>D&#x000ed;az</surname><given-names>S</given-names></name>, <name><surname>Mejia-Villatoro</surname><given-names>C</given-names></name>. <chapter-title>An&#x000e1;lisis de la vigilancia epidemiol&#x000f3;gica de VIH y Sida del Hospital Roosevelt, Guatemala 2002&#x02013;2010</chapter-title>
<publisher-loc>Guatemala</publisher-loc>: <publisher-name>Hospital Roosevelt, Ministerio de Salud P&#x000fa;blica y Asistencia Social</publisher-name>
<year>2011</year> Available from: <ext-link ext-link-type="uri" xlink:href="http://docplayer.es/13349096-Amalia-carolina-giron-callejas-trabajos-finales-nivel-intermedio.html">http://docplayer.es/13349096-Amalia-carolina-giron-callejas-trabajos-finales-nivel-intermedio.html</ext-link>.</mixed-citation></ref><ref id="pone.0203916.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Garcia</surname><given-names>JI</given-names></name>, <name><surname>Samayoa</surname><given-names>B</given-names></name>, <name><surname>Sabido</surname><given-names>M</given-names></name>, <name><surname>Prieto</surname><given-names>LA</given-names></name>, <name><surname>Nikiforov</surname><given-names>M</given-names></name>, <name><surname>Pinzon</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>The MANGUA Project: A Population-Based HIV Cohort in Guatemala</article-title>. <source>AIDS Res Treat</source>. <year>2015</year>;<volume>2015</volume>:<fpage>372816</fpage>
<pub-id pub-id-type="doi">10.1155/2015/372816</pub-id> ; PubMed Central PMCID: PMCPMC4575727.<?supplied-pmid 26425365?><pub-id pub-id-type="pmid">26425365</pub-id></mixed-citation></ref><ref id="pone.0203916.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Thompson</surname><given-names>JD</given-names></name>, <name><surname>Gibson</surname><given-names>TJ</given-names></name>, <name><surname>Plewniak</surname><given-names>F</given-names></name>, <name><surname>Jeanmougin</surname><given-names>F</given-names></name>, <name><surname>Higgins</surname><given-names>DG</given-names></name>. <article-title>The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools</article-title>. <source>Nucleic acids research</source>. <year>1997</year>;<volume>25</volume>:<fpage>4876</fpage>&#x02013;<lpage>82</lpage>. <?supplied-pmid 9396791?><pub-id pub-id-type="pmid">9396791</pub-id></mixed-citation></ref><ref id="pone.0203916.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Tamura</surname><given-names>K</given-names></name>, <name><surname>Dudley</surname><given-names>J</given-names></name>, <name><surname>Nei</surname><given-names>M</given-names></name>, <name><surname>Kumar</surname><given-names>S</given-names></name>. <article-title>MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0</article-title>. <source>Molecular biology and evolution</source>. <year>2007</year>;<volume>24</volume>(<issue>8</issue>):<fpage>1596</fpage>&#x02013;<lpage>9</lpage>. Epub 2007/05/10. <pub-id pub-id-type="doi">10.1093/molbev/msm092</pub-id> .<?supplied-pmid 17488738?><pub-id pub-id-type="pmid">17488738</pub-id></mixed-citation></ref><ref id="pone.0203916.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>de Oliveira</surname><given-names>T</given-names></name>, <name><surname>Deforche</surname><given-names>K</given-names></name>, <name><surname>Cassol</surname><given-names>S</given-names></name>, <name><surname>Salminen</surname><given-names>M</given-names></name>, <name><surname>Paraskevis</surname><given-names>D</given-names></name>, <name><surname>Seebregts</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>An automated genotyping system for analysis of HIV-1 and other microbial sequences</article-title>. <source>Bioinformatics</source>. <year>2005</year>;<volume>21</volume>(<issue>19</issue>):<fpage>3797</fpage>&#x02013;<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bti607</pub-id> .<?supplied-pmid 16076886?><pub-id pub-id-type="pmid">16076886</pub-id></mixed-citation></ref><ref id="pone.0203916.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Posada</surname><given-names>D.</given-names></name>
<article-title>jModelTest: phylogenetic model averaging</article-title>. <source>Mol Biol Evol</source>. <year>2008</year>;<volume>25</volume>(<issue>7</issue>):<fpage>1253</fpage>&#x02013;<lpage>6</lpage>. Epub 2008/04/10. doi: msn083 [pii] <pub-id pub-id-type="doi">10.1093/molbev/msn083</pub-id> .<?supplied-pmid 18397919?><pub-id pub-id-type="pmid">18397919</pub-id></mixed-citation></ref><ref id="pone.0203916.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Guindon</surname><given-names>S</given-names></name>, <name><surname>Gascuel</surname><given-names>O</given-names></name>. <article-title>A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood</article-title>. <source>Syst Biol</source>. <year>2003</year>;<volume>52</volume>(<issue>5</issue>):<fpage>696</fpage>&#x02013;<lpage>704</lpage>. .<?supplied-pmid 14530136?><pub-id pub-id-type="pmid">14530136</pub-id></mixed-citation></ref><ref id="pone.0203916.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Guindon</surname><given-names>S</given-names></name>, <name><surname>Lethiec</surname><given-names>F</given-names></name>, <name><surname>Duroux</surname><given-names>P</given-names></name>, <name><surname>Gascuel</surname><given-names>O</given-names></name>. <article-title>PHYML Online&#x02014;a web server for fast maximum likelihood-based phylogenetic inference</article-title>. <source>Nucleic Acids Res</source>. <year>2005</year>;<volume>33</volume>(Web Server issue):<fpage>W557</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gki352</pub-id> .<?supplied-pmid 15980534?><pub-id pub-id-type="pmid">15980534</pub-id></mixed-citation></ref><ref id="pone.0203916.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Anisimova</surname><given-names>M</given-names></name>, <name><surname>Gascuel</surname><given-names>O</given-names></name>. <article-title>Approximate likelihood-ratio test for branches: A fast, accurate, and powerful alternative</article-title>. <source>Syst Biol</source>. <year>2006</year>;<volume>55</volume>(<issue>4</issue>):<fpage>539</fpage>&#x02013;<lpage>52</lpage>. Epub 2006/06/21. <pub-id pub-id-type="doi">10.1080/10635150600755453</pub-id> .<?supplied-pmid 16785212?><pub-id pub-id-type="pmid">16785212</pub-id></mixed-citation></ref><ref id="pone.0203916.ref025"><label>25</label><mixed-citation publication-type="other">Rambaut A. FigTree v1.4: Tree Figure Drawing Tool. Available from: <ext-link ext-link-type="uri" xlink:href="http://treebioedacuk/software/figtree/">http://treebioedacuk/software/figtree/</ext-link>. Accessed 2013 June 20. 2009.</mixed-citation></ref><ref id="pone.0203916.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Drummond</surname><given-names>AJ</given-names></name>, <name><surname>Nicholls</surname><given-names>GK</given-names></name>, <name><surname>Rodrigo</surname><given-names>AG</given-names></name>, <name><surname>Solomon</surname><given-names>W</given-names></name>. <article-title>Estimating mutation parameters, population history and genealogy simultaneously from temporally spaced sequence data</article-title>. <source>Genetics</source>. <year>2002</year>;<volume>161</volume>(<issue>3</issue>):<fpage>1307</fpage>&#x02013;<lpage>20</lpage>. .<?supplied-pmid 12136032?><pub-id pub-id-type="pmid">12136032</pub-id></mixed-citation></ref><ref id="pone.0203916.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Drummond</surname><given-names>AJ</given-names></name>, <name><surname>Rambaut</surname><given-names>A</given-names></name>. <article-title>BEAST: Bayesian evolutionary analysis by sampling trees</article-title>. <source>BMC Evol Biol</source>. <year>2007</year>;<volume>7</volume>:<fpage>214</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2148-7-214</pub-id> .<?supplied-pmid 17996036?><pub-id pub-id-type="pmid">17996036</pub-id></mixed-citation></ref><ref id="pone.0203916.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Suchard</surname><given-names>MA</given-names></name>, <name><surname>Rambaut</surname><given-names>A</given-names></name>. <article-title>Many-core algorithms for statistical phylogenetics</article-title>. <source>Bioinformatics</source>. <year>2009</year>;<volume>25</volume>(<issue>11</issue>):<fpage>1370</fpage>&#x02013;<lpage>6</lpage>. Epub 2009/04/17. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp244</pub-id> ; PubMed Central PMCID: PMC2682525.<?supplied-pmid 19369496?><pub-id pub-id-type="pmid">19369496</pub-id></mixed-citation></ref><ref id="pone.0203916.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Drummond</surname><given-names>AJ</given-names></name>, <name><surname>Ho</surname><given-names>SY</given-names></name>, <name><surname>Phillips</surname><given-names>MJ</given-names></name>, <name><surname>Rambaut</surname><given-names>A</given-names></name>. <article-title>Relaxed phylogenetics and dating with confidence</article-title>. <source>PLoS Biol</source>. <year>2006</year>;<volume>4</volume>(<issue>5</issue>):<fpage>e88</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pbio.0040088</pub-id> .<?supplied-pmid 16683862?><pub-id pub-id-type="pmid">16683862</pub-id></mixed-citation></ref><ref id="pone.0203916.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Lemey</surname><given-names>P</given-names></name>, <name><surname>Rambaut</surname><given-names>A</given-names></name>, <name><surname>Drummond</surname><given-names>AJ</given-names></name>, <name><surname>Suchard</surname><given-names>MA</given-names></name>. <article-title>Bayesian phylogeography finds its roots</article-title>. <source>PLoS Comput Biol</source>. <year>2009</year>;<volume>5</volume>(<issue>9</issue>):<fpage>e1000520</fpage> Epub 2009/09/26. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1000520</pub-id> ; PubMed Central PMCID: PMC2740835.<?supplied-pmid 19779555?><pub-id pub-id-type="pmid">19779555</pub-id></mixed-citation></ref><ref id="pone.0203916.ref031"><label>31</label><mixed-citation publication-type="other">Rambaut A, Drummond A. Tracer v1.6. Available: <ext-link ext-link-type="uri" xlink:href="http://treebioedacuk/software/tracer/">http://treebioedacuk/software/tracer/</ext-link>. Accessed 2013 June 20. 2007.</mixed-citation></ref><ref id="pone.0203916.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Bielejec</surname><given-names>F</given-names></name>, <name><surname>Rambaut</surname><given-names>A</given-names></name>, <name><surname>Suchard</surname><given-names>MA</given-names></name>, <name><surname>Lemey</surname><given-names>P</given-names></name>. <article-title>SPREAD: spatial phylogenetic reconstruction of evolutionary dynamics</article-title>. <source>Bioinformatics</source>. <year>2011</year>;<volume>27</volume>(<issue>20</issue>):<fpage>2910</fpage>&#x02013;<lpage>2</lpage>. Epub 2011/09/14. <pub-id pub-id-type="doi">10.1093/bioinformatics/btr481</pub-id> ; PubMed Central PMCID: PMC3187652.<?supplied-pmid 21911333?><pub-id pub-id-type="pmid">21911333</pub-id></mixed-citation></ref><ref id="pone.0203916.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Drummond</surname><given-names>AJ</given-names></name>, <name><surname>Rambaut</surname><given-names>A</given-names></name>, <name><surname>Shapiro</surname><given-names>B</given-names></name>, <name><surname>Pybus</surname><given-names>OG</given-names></name>. <article-title>Bayesian coalescent inference of past population dynamics from molecular sequences</article-title>. <source>Mol Biol Evol</source>. <year>2005</year>;<volume>22</volume>(<issue>5</issue>):<fpage>1185</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msi103</pub-id> .<?supplied-pmid 15703244?><pub-id pub-id-type="pmid">15703244</pub-id></mixed-citation></ref><ref id="pone.0203916.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Baele</surname><given-names>G</given-names></name>, <name><surname>Lemey</surname><given-names>P</given-names></name>, <name><surname>Bedford</surname><given-names>T</given-names></name>, <name><surname>Rambaut</surname><given-names>A</given-names></name>, <name><surname>Suchard</surname><given-names>MA</given-names></name>, <name><surname>Alekseyenko</surname><given-names>AV</given-names></name>. <article-title>Improving the accuracy of demographic and molecular clock model comparison while accommodating phylogenetic uncertainty</article-title>. <source>Molecular biology and evolution</source>. <year>2012</year>;<volume>29</volume>(<issue>9</issue>):<fpage>2157</fpage>&#x02013;<lpage>67</lpage>. Epub 2012/03/10. <pub-id pub-id-type="doi">10.1093/molbev/mss084</pub-id> ; PubMed Central PMCID: PMC3424409.<?supplied-pmid 22403239?><pub-id pub-id-type="pmid">22403239</pub-id></mixed-citation></ref><ref id="pone.0203916.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Crabtree-Ramirez</surname><given-names>B</given-names></name>, <name><surname>Caro-Vega</surname><given-names>Y</given-names></name>, <name><surname>Shepherd</surname><given-names>BE</given-names></name>, <name><surname>Wehbe</surname><given-names>F</given-names></name>, <name><surname>Cesar</surname><given-names>C</given-names></name>, <name><surname>Cortes</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters</article-title>. <source>PloS one</source>. <year>2011</year>;<volume>6</volume>(<issue>5</issue>):<fpage>e20272</fpage> Epub 2011/06/04. <pub-id pub-id-type="doi">10.1371/journal.pone.0020272</pub-id> ; PubMed Central PMCID: PMC3102699.<?supplied-pmid 21637802?><pub-id pub-id-type="pmid">21637802</pub-id></mixed-citation></ref><ref id="pone.0203916.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Mir</surname><given-names>D</given-names></name>, <name><surname>Cabello</surname><given-names>M</given-names></name>, <name><surname>Romero</surname><given-names>H</given-names></name>, <name><surname>Bello</surname><given-names>G</given-names></name>. <article-title>Phylodynamics of major HIV-1 subtype B pandemic clades circulating in Latin America</article-title>. <source>AIDS</source>. <year>2015</year>;<volume>29</volume>(<issue>14</issue>):<fpage>1863</fpage>&#x02013;<lpage>9</lpage>. Epub 2015/09/16. <pub-id pub-id-type="doi">10.1097/QAD.0000000000000770</pub-id> .<?supplied-pmid 26372392?><pub-id pub-id-type="pmid">26372392</pub-id></mixed-citation></ref><ref id="pone.0203916.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Cabello</surname><given-names>M</given-names></name>, <name><surname>Junqueira</surname><given-names>DM</given-names></name>, <name><surname>Bello</surname><given-names>G</given-names></name>. <article-title>Dissemination of nonpandemic Caribbean HIV-1 subtype B clades in Latin America</article-title>. <source>AIDS</source>. <year>2015</year>;<volume>29</volume>(<issue>4</issue>):<fpage>483</fpage>&#x02013;<lpage>92</lpage>. Epub 2015/01/30. <pub-id pub-id-type="doi">10.1097/QAD.0000000000000552</pub-id> .<?supplied-pmid 25630042?><pub-id pub-id-type="pmid">25630042</pub-id></mixed-citation></ref><ref id="pone.0203916.ref038"><label>38</label><mixed-citation publication-type="book"><name><surname>Morales-Miranda</surname><given-names>S</given-names></name>, <name><surname>Alvarez-Rodriguez</surname><given-names>B</given-names></name>, <name><surname>Arambu</surname><given-names>N</given-names></name>, <name><surname>Aguilar</surname><given-names>J</given-names></name>, <name><surname>Huam&#x000e1;n</surname><given-names>B</given-names></name>, <name><surname>Figueroa</surname><given-names>W</given-names></name>, <etal>et al</etal>
<chapter-title>Encuesta de Vigilancia de Comportamiento Sexual y Prevalencia del VIH e ITS, en poblaciones vulnerables y poblaciones clave</chapter-title>
<publisher-loc>Guatemala</publisher-loc>: <publisher-name>Universidad del Valle de Guatemala</publisher-name>, <year>2013</year>.</mixed-citation></ref><ref id="pone.0203916.ref039"><label>39</label><mixed-citation publication-type="book"><name><surname>Arias</surname><given-names>J.</given-names></name>
<chapter-title>Demograf&#x000ed;a de Guatemala</chapter-title> In: <name><surname>Lima</surname><given-names>FR</given-names></name>, editor. <source>&#x000c9;poca contemporanea: de 1945 a la actualidad. Historia General de Guatemala. VI. Guatemala</source>: <publisher-name>Fundaci&#x000f3;n para la Cultura y el Desarrollo</publisher-name>; <year>1997</year> p. <fpage>195</fpage>&#x02013;<lpage>213</lpage>.</mixed-citation></ref><ref id="pone.0203916.ref040"><label>40</label><mixed-citation publication-type="book"><name><surname>Aguilera</surname><given-names>G.</given-names></name>
<chapter-title>La Guerra Interna, 1960&#x02013;1994</chapter-title> In: <name><surname>Rojas</surname><given-names>F</given-names></name>, editor. <source>&#x000c9;poca contemporanea: de 1945 a la actualidad. Historia General de Guatemala. VI. Guatemala</source>: <publisher-name>Fundaci&#x000f3;n para la Cultura y el Desarrollo</publisher-name>; <year>1997</year> p. <fpage>135</fpage>&#x02013;<lpage>51</lpage>.</mixed-citation></ref><ref id="pone.0203916.ref041"><label>41</label><mixed-citation publication-type="book"><name><surname>Schroten</surname><given-names>H.</given-names></name>
<chapter-title>La migraci&#x000f3;n interna en Guatemala durante el per&#x000ed;odo 1976&#x02013;1981</chapter-title>
<publisher-name>Notas de Poblaci&#x000f3;n</publisher-name>
<year>1987</year>.</mixed-citation></ref><ref id="pone.0203916.ref042"><label>42</label><mixed-citation publication-type="other">Caballeros &#x000c1;. Perfil migratorio de Guatemala 2012. 2013.</mixed-citation></ref><ref id="pone.0203916.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Leyva-Flores</surname><given-names>R</given-names></name>, <name><surname>Aracena-Genao</surname><given-names>B</given-names></name>, <name><surname>Serv&#x000e1;n-Mori</surname><given-names>E</given-names></name>. <article-title>Movilidad poblacional y VIH/sida en Centroam&#x000e9;rica y M&#x000e9;xico</article-title>. <source>Rev Panam Salud Publica</source>. <year>2014</year>;<volume>36</volume>(<issue>6</issue>):<fpage>143</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">25418763</pub-id></mixed-citation></ref><ref id="pone.0203916.ref044"><label>44</label><mixed-citation publication-type="book"><name><surname>Montejo</surname><given-names>V.</given-names></name>
<chapter-title>Los Refugiados Guatemaltecos en M&#x000e9;xico, 1981&#x02013;1992</chapter-title> In: <name><surname>Rojas</surname><given-names>F</given-names></name>, editor. <source>&#x000c9;poca contemporanea: de 1945 a la actualidad. Historia General de Guatemala. VI. Guatemala</source>: <publisher-name>Fundaci&#x000f3;n para la Cultura y el Desarrollo</publisher-name>; <year>1997</year> p. <fpage>367</fpage>&#x02013;<lpage>79</lpage>.</mixed-citation></ref><ref id="pone.0203916.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Hue</surname><given-names>S</given-names></name>, <name><surname>Pillay</surname><given-names>D</given-names></name>, <name><surname>Clewley</surname><given-names>JP</given-names></name>, <name><surname>Pybus</surname><given-names>OG</given-names></name>. <article-title>Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2005</year>;<volume>102</volume>(<issue>12</issue>):<fpage>4425</fpage>&#x02013;<lpage>9</lpage>. Epub 2005/03/16. <pub-id pub-id-type="doi">10.1073/pnas.0407534102</pub-id> ; PubMed Central PMCID: PMC555492.<?supplied-pmid 15767575?><pub-id pub-id-type="pmid">15767575</pub-id></mixed-citation></ref><ref id="pone.0203916.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Zehender</surname><given-names>G</given-names></name>, <name><surname>Ebranati</surname><given-names>E</given-names></name>, <name><surname>Lai</surname><given-names>A</given-names></name>, <name><surname>Santoro</surname><given-names>MM</given-names></name>, <name><surname>Alteri</surname><given-names>C</given-names></name>, <name><surname>Giuliani</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Population Dynamics of HIV-1 Subtype B in a Cohort of Men-Having-Sex-With-Men in Rome, Italy</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2010</year>;<volume>55</volume>(<issue>2</issue>):<fpage>156</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1097/QAI.0b013e3181eb3002</pub-id>
<?supplied-pmid 20703157?><pub-id pub-id-type="pmid">20703157</pub-id></mixed-citation></ref><ref id="pone.0203916.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>JH-K</given-names></name>, <name><surname>Wong</surname><given-names>K-H</given-names></name>, <name><surname>Chan</surname><given-names>KC-W</given-names></name>, <name><surname>To</surname><given-names>SW-C</given-names></name>, <name><surname>Chen</surname><given-names>Z</given-names></name>, <name><surname>Yam</surname><given-names>W-C</given-names></name>. <article-title>Phylodynamics of HIV-1 Subtype B among the Men-Having-Sex-with-Men (MSM) Population in Hong Kong</article-title>. <source>PloS one</source>. <year>2011</year>;<volume>6</volume> doi:(9):e25286. <pub-id pub-id-type="doi">10.1371/journal.pone.0025286.t001</pub-id></mixed-citation></ref><ref id="pone.0203916.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Delatorre</surname><given-names>EO</given-names></name>, <name><surname>Bello</surname><given-names>G</given-names></name>. <article-title>Phylodynamics of the HIV-1 Epidemic in Cuba</article-title>. <source>PloS one</source>. <year>2013</year>;<volume>8</volume>(<issue>9</issue>):<fpage>e72448</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0072448</pub-id>
<?supplied-pmid 24039765?><pub-id pub-id-type="pmid">24039765</pub-id></mixed-citation></ref></ref-list></back></article>